| Year |
Title |
Altmetric |
| 2023
|
Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study..
Journal of Neurology.
2023
|
|
| 2023
|
Primary results of a phase-III, randomized controlled trial of the Behavioral Intervention for increasing Physical Activity in Multiple Sclerosis project
2023
|
|
| 2023
|
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis.
Journal of Neurology.
270:1543-1563.
2023
|
|
| 2023
|
Exploratory clinical efficacy and patient-reported outcomes from NOVA: a randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis.
Multiple Sclerosis and Related Disorders.
104561.
2023
|
|
| 2023
|
Randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis project: Secondary, patient-reported outcomes.
Contemporary Clinical Trials.
125.
2023
|
|
| 2023
|
Attitudes of people with multiple sclerosis toward brain donation.
Frontiers in Neurology.
14.
2023
|
|
| 2023
|
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
2023
|
|
| 2023
|
Diet, Physical Activity, and Stress Among Wheelchair Users With Multiple Sclerosis: Examining Individual and Co-Occurring Behavioral Risk Factors.
Archives of Physical Medicine and Rehabilitation.
2023
|
|
| 2023
|
Impact of the COVID-19 pandemic on patients with myasthenia gravis: A survey of the Myasthenia Gravis Foundation of America MG patient registry.
Muscle and Nerve.
67:25-32.
2023
|
|
| 2023
|
The best and worst of times in therapy development for myasthenia gravis.
Muscle and Nerve.
67:12-16.
2023
|
|
| 2023
|
The nine hole peg test as an outcome measure in progressive MS trials.
Multiple Sclerosis and Related Disorders.
69.
2023
|
|
| 2022
|
Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy
2022
|
|
| 2022
|
Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease: Phase 2 proof‐of‐concept clinical trial using hippocampal volume as a surrogate endpoint.
Alzheimer's and Dementia.
18.
2022
|
|
| 2022
|
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
EBioMedicine.
86.
2022
|
|
| 2022
|
Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.
Antimicrobial Resistance and Infection Control.
11.
2022
|
|
| 2022
|
Diet, Physical Activity, and Stress Among Wheelchair Users with Multiple Sclerosis: Examining Behavioral Risk Factors.
Archives of Physical Medicine and Rehabilitation.
103:e180-e181.
2022
|
|
| 2022
|
SARS-CoV-2 infection increases risk of acute kidney injury in a bimodal age distribution.
BMC Nephrology.
23.
2022
|
|
| 2022
|
The emerging postural instability phenotype in idiopathic Parkinson disease.
npj Parkinson's Disease.
8.
2022
|
|
| 2022
|
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study.
Journal of Neurology.
269:6202-6210.
2022
|
|
| 2022
|
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial.
American Journal of the Medical Sciences.
364:538-546.
2022
|
|
| 2022
|
Treatment for Mild Chronic Hypertension During Pregnancy.
Obstetrical and Gynecological Survey.
77:634-636.
2022
|
|
| 2022
|
Advocating for in-center hemodialysis patients via anonymous survey.
Medicine.
101:E30937.
2022
|
|
| 2022
|
Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis.
Neurology.
99:E1538-E1548.
2022
|
|
| 2022
|
Lactated Ringer's solution and risk of hyperkalemia in patients with reduced kidney function: Safety of Lactated Ringer's in kidney disease.
American Journal of the Medical Sciences.
364:433-443.
2022
|
|
| 2022
|
One-year follow-up of disease burden and medication changes in patients with myasthenia gravis: From the MG Patient Registry.
Muscle and Nerve.
66:411-420.
2022
|
|
| 2022
|
T55. POLYGENICITY OF COMORBID DEPRESSION IN MULTIPLE SCLEROSIS.
European Neuropsychopharmacology.
63:e198.
2022
|
|
| 2022
|
Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis.
Journal of Neurology.
269:5531-5540.
2022
|
|
| 2022
|
The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis
2022
|
|
| 2022
|
The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial dataset.
Journal of Neurology.
269:5319-5327.
2022
|
|
| 2022
|
136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS.
Journal of Neurology, Neurosurgery and Psychiatry.
93:e2.91.
2022
|
|
| 2022
|
COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes.
Multiple Sclerosis and Related Disorders.
65.
2022
|
|
| 2022
|
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
2022
|
|
| 2022
|
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
New England Journal of Medicine.
387:704-714.
2022
|
|
| 2022
|
Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis.
Neurology: Clinical Practice.
12:E58-E65.
2022
|
|
| 2022
|
Treatment for Mild Chronic Hypertension During Pregnancy.
Obstetrical and Gynecological Survey.
77:460-462.
2022
|
|
| 2022
|
Absolute quantification of plasma mitochondrial DNA by droplet digital PCR marks COVID-19 severity over time during intensive care unit admissions
2022
|
|
| 2022
|
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Lancet Neurology.
21:608-619.
2022
|
|
| 2022
|
Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseases.
Multiple Sclerosis and Related Disorders.
63.
2022
|
|
| 2022
|
Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS
2022
|
|
| 2022
|
The Potential for EBV Vaccines to Prevent Multiple Sclerosis.
Frontiers in Neurology.
13.
2022
|
|
| 2022
|
Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple Sclerosis.
Frontiers in Neurology.
13.
2022
|
|
| 2022
|
036 Ocrelizumab real-world effectiveness in patients with relapsing and primary progressive multiple sclerosis: MuSicalE baseline data.
Journal of Neurology, Neurosurgery and Psychiatry.
93:a24.3-a2a25.
2022
|
|
| 2022
|
COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings.
Arthritis and Rheumatology.
74:1091-1092.
2022
|
|
| 2022
|
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study
2022
|
|
| 2022
|
Disparities in Telehealth Care in Multiple Sclerosis.
Neurology: Clinical Practice.
12:223-233.
2022
|
|
| 2022
|
Treatment for Mild Chronic Hypertension during Pregnancy.
New England Journal of Medicine.
386:1781-1792.
2022
|
|
| 2022
|
Subsurface Eddy Facilitates Retention of Simulated Diel Vertical Migrators in a Biological Hotspot.
Journal of Geophysical Research: Oceans.
127.
2022
|
|
| 2022
|
The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions.
Multiple Sclerosis and Related Disorders.
61.
2022
|
|
| 2022
|
Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis.
Multiple Sclerosis Journal - Experimental, Translational and Clinical.
8.
2022
|
|
| 2022
|
Do physical activity, cardiorespiratory fitness, and subcortical brain structures explain reduced walking performance in older adults with multiple sclerosis?.
Multiple Sclerosis and Related Disorders.
60.
2022
|
|
| 2022
|
Early first-line treatment response and subsequent disability worsening in relapsing–remitting multiple sclerosis.
European Journal of Neurology.
29:1106-1116.
2022
|
|
| 2022
|
Exercise training in multiple sclerosis.
Lancet Neurology.
21:313.
2022
|
|
| 2022
|
MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis
2022
|
|
| 2022
|
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient.
Multiple Sclerosis and Related Disorders.
60.
2022
|
|
| 2022
|
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial
2022
|
|
| 2022
|
Perceptions of physical activity guidelines among wheelchair users with multiple sclerosis.
Multiple Sclerosis Journal - Experimental, Translational and Clinical.
8.
2022
|
|
| 2022
|
Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies.
Multiple Sclerosis and Related Disorders.
60.
2022
|
|
| 2022
|
Résultats primaires de NOVA : une étude contrôlée randomisée comparant l’administration de natalizumab toutes les 6 semaines versus une administration continue toutes les 4 semaines dans le traitement de la sclérose en plaques.
Revue Neurologique.
178:s119-s120.
2022
|
|
| 2022
|
Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple Sclerosis.
Neurology: Clinical Practice.
12:102-112.
2022
|
|
| 2022
|
The Non-Inferiority Complex: What Do Non-Inferiority Trials Tell Us?.
Journal of the American Society of Nephrology.
33:674-676.
2022
|
|
| 2022
|
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience.
Journal of Neurology.
269:1758-1763.
2022
|
|
| 2022
|
A Systematic Method to Explore Radio-Frequency Non-Thermal Effect on the Growth of Saccharomyces Cerevisiae.
IEEE Journal of Electromagnetics Rf and Microwaves in Medicine and Biology.
6:52-60.
2022
|
|
| 2022
|
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials.
European Journal of Neurology.
29:843-854.
2022
|
|
| 2022
|
Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis.
Multiple Sclerosis and Related Disorders.
59:103626.
2022
|
|
| 2022
|
Smoking, obesity, and disability worsening in PPMS: an analysis of the INFORMS original trial dataset.
Journal of Neurology.
269:1663-1669.
2022
|
|
| 2022
|
Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial.
European Journal of Neurology.
29:515-521.
2022
|
|
| 2022
|
Mendelian randomization in the multivariate general linear model framework.
Genetic Epidemiology.
46:17-31.
2022
|
|
| 2022
|
The timed 25-foot walk in a large cohort of multiple sclerosis patients
2022
|
|
| 2022
|
Video Telehealth Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Is Associated with Clinical Improvement Similar to Center-based Pulmonary Rehabilitation.
Annals of the American Thoracic Society.
19:332-335.
2022
|
|
| 2022
|
Multiple Sclerosis Diagnostic Criteria: Moving Ahead or Walking in Place?.
Neurology.
98:12-13.
2022
|
|
| 2022
|
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Multiple Sclerosis and Related Disorders.
57.
2022
|
|
| 2022
|
Effects of exercise on sleep spindles in Parkinson's disease..
Frontiers in Rehabilitation Sciences.
3:952289.
2022
|
|
| 2022
|
Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.
Journal of Alzheimer's Disease.
87:489-501.
2022
|
|
| 2022
|
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS
2022
|
|
| 2022
|
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease
2022
|
|
| 2022
|
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.
Journal of Parkinson's Disease.
12:557-570.
2022
|
|
| 2022
|
The sequential natalizumab - alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial - Part I: Rationale and objectives..
Journal of Central Nervous System Disease.
14:11795735221123911.
2022
|
|
| 2022
|
White matter tracts that overlap with the thalamus and the putamen are protected against multiple sclerosis pathology.
Multiple Sclerosis and Related Disorders.
57.
2022
|
|
| 2021
|
Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis.
Frontiers in Neurology.
12.
2021
|
|
| 2021
|
Accuracy and Repeatability of Internet-ordered Spectacle Lenses.
Optometry and Vision Science.
98:1340-1347.
2021
|
|
| 2021
|
Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.
European Journal of Neurology.
28:4135-4145.
2021
|
|
| 2021
|
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.
Laboratory Investigation.
101:1585-1596.
2021
|
|
| 2021
|
Diet quality assessment in wheelchair users with multiple sclerosis.
Nutrients.
13.
2021
|
|
| 2021
|
Hydroxychloroquine for Primary Progressive Multiple Sclerosis.
Annals of Neurology.
90:940-948.
2021
|
|
| 2021
|
Profile of Autism Spectrum Disorder in Tuberous Sclerosis Complex: Results from a Longitudinal, Prospective, Multisite Study.
Annals of Neurology.
90:874-886.
2021
|
|
| 2021
|
Arteriovenous Fistula Nonmaturation: What's the Immune System Got to Do with It?
2021
|
|
| 2021
|
A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis.
International Journal of MS Care.
23:245-252.
2021
|
|
| 2021
|
Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate.
International Journal of MS Care.
23:239-244.
2021
|
|
| 2021
|
Effects of walking exercise training on learning and memory and hippocampal neuroimaging outcomes in MS: A targeted, pilot randomized controlled trial.
Contemporary Clinical Trials.
110.
2021
|
|
| 2021
|
Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: A pilot two-arm trial.
Rheumatology.
60:5002-5011.
2021
|
|
| 2021
|
NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights.
International Journal of MS Care.
23:276-285.
2021
|
|
| 2021
|
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD
2021
|
|
| 2021
|
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
Neurology.
97:E1560-E1570.
2021
|
|
| 2021
|
A comparison of clinical outcomes in PPMS in the INFORMS original trial data set
2021
|
|
| 2021
|
An enrichment strategy for clinical trials in SPMS
2021
|
|
| 2021
|
Cannabis Use for Symptom Management Among People with Multiple Sclerosis (PwMS): A 2020 NARCOMS Survey.
Archives of Physical Medicine and Rehabilitation.
102:e23-e24.
2021
|
|
| 2021
|
Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis
2021
|
|
| 2021
|
Demographic, clinical, and symptomatic correlates of subjective sleep quality in adults with multiple sclerosis.
Multiple Sclerosis and Related Disorders.
55.
2021
|
|
| 2021
|
If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?.
Neurotherapeutics.
18:2419-2420.
2021
|
|
| 2021
|
Physical activity and self-reported sleep quality in adults with multiple sclerosis.
Disability and Health Journal.
14.
2021
|
|
| 2021
|
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum.
Neurology.
97:e1334-e1342.
2021
|
|
| 2021
|
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry
2021
|
|
| 2021
|
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy.
Epilepsy and Behavior.
122.
2021
|
|
| 2021
|
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam (MG-CE).
Muscle and Nerve.
64:270-276.
2021
|
|
| 2021
|
How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity..
Neurology: Clinical Practice.
11:335-341.
2021
|
|
| 2021
|
Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Arthritis and Rheumatology.
73:1523-1532.
2021
|
|
| 2021
|
The Importance and Opportunity for Healthy Aging Through Lifestyle, Behavior Medicine Among Older Adults With Multiple Sclerosis: the Case Based on Physical Activity.
Current Treatment Options in Neurology.
23.
2021
|
|
| 2021
|
Uptake and Attitudes About Immunizations in People With Multiple Sclerosis..
Neurology: Clinical Practice.
11:327-334.
2021
|
|
| 2021
|
A novel Mendelian randomization method with binary risk factor and outcome.
Genetic Epidemiology.
45:549-560.
2021
|
|
| 2021
|
Abstract 1747: Oncolytic Vesicular Stomatitis Virus expressing a species relevant interferon-beta is safe and provides a survival benefit when added as neoadjuvant to the standard of care for dogs with naturally occurring bone cancer.
Cancer Research.
81:1747-1747.
2021
|
|
| 2021
|
Abstract 671: Development of an exosomal biomarker signature to detect minimal residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.
Cancer Research.
81:671-671.
2021
|
|
| 2021
|
Artificial intelligence extension of the OSCAR-IB criteria.
Annals of Clinical and Translational Neurology.
8:1528-1542.
2021
|
|
| 2021
|
Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease
2021
|
|
| 2021
|
Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?.
European Journal of Neurology.
28:2115-2120.
2021
|
|
| 2021
|
Outcomes and Risk Factors Associated with SARS-CoV-2 Infection in a North American Registry of Patients with Multiple Sclerosis.
JAMA Neurology.
78:699-708.
2021
|
|
| 2021
|
POS0135 REDUCING IMMUNOGENICITY OF PEGLOTICASE (RECIPE) WITH CONCOMITANT USE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH REFRACTORY GOUT: A PHASE II RANDOMIZED CONTROLLED TRIAL.
Annals of the Rheumatic Diseases.
80:279-280.
2021
|
|
| 2021
|
Acute flaccid myelitis: Long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis.
BMJ Neurology Open.
3.
2021
|
|
| 2021
|
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.
Neurology.
96:e2313-e2322.
2021
|
|
| 2021
|
521 Prevalence and Impact of Restless Legs in Patients with Myasthenia Gravis.
Sleep.
44:a205-a206.
2021
|
|
| 2021
|
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder
2021
|
|
| 2021
|
Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: A cross-sectional study.
Multiple Sclerosis and Related Disorders.
50.
2021
|
|
| 2021
|
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.
Annals of Neurology.
89:895-910.
2021
|
|
| 2021
|
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis.
Journal of Neurology.
268:1598-1607.
2021
|
|
| 2021
|
UAB-UCSD o'brien center for acute kidney injury research
2021
|
|
| 2021
|
Améliorations des scores SymptoMScreen rapportés par les patients atteints de sclérose en plaques récurrente-rémittente (SEP-RR) traités par ocrelizumab (OCR) : résultats à 2 ans de l’étude CASTING.
Revue Neurologique.
177:s107-s108.
2021
|
|
| 2021
|
Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy.
Epilepsy and Behavior.
117.
2021
|
|
| 2021
|
NF106: A neurofibromatosis clinical trials consortium phase II trial of the MEK inhibitor mirdametinib (PD-0325901) in adolescents and adults with NF1-related plexiform neurofibromas.
Journal of Clinical Oncology.
39:797-806.
2021
|
|
| 2021
|
Randomized trial testing an online responsible vendor training in recreational Marijuana stores in the United States.
Journal of Studies on Alcohol and Drugs.
82:204-213.
2021
|
|
| 2021
|
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning
2021
|
|
| 2021
|
CSF plasmablasts differentiate MS from other neurologic disorders.
Multiple Sclerosis and Related Disorders.
48.
2021
|
|
| 2021
|
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.
Neurology.
96:e214-e227.
2021
|
|
| 2021
|
Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis.
Neurology.
96:E111-E120.
2021
|
|
| 2021
|
A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod.
Therapeutic Advances in Neurological Disorders.
14.
2021
|
|
| 2021
|
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial.
Nature Medicine.
27:165-173.
2021
|
|
| 2021
|
Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.
NeuroImage: Clinical.
32.
2021
|
|
| 2021
|
Disease-modifying therapy prescription patterns in people with multiple sclerosis by age.
Therapeutic Advances in Neurological Disorders.
14.
2021
|
|
| 2021
|
New applications for independent activities of daily living in measuring disability in multiple sclerosis
2021
|
|
| 2021
|
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients With Parkinson's Disease and a GBA Mutation: Results From Part 1 of the Randomised, Double-Blinded, Placebo-Controlled MOVES-PD Trial
2021
|
|
| 2021
|
Slow Wave Sleep and EEG Delta Spectral Power are Associated with Cognitive Function in Parkinson's Disease.
Journal of Parkinson's Disease.
11:703-714.
2021
|
|
| 2021
|
The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing-Remitting Multiple sclerosis: A CombiRx Secondary Analysis..
Journal of Central Nervous System Disease.
13:11795735211042173.
2021
|
|
| 2020
|
NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY.
Neuro-Oncology.
22:iii419-iii419.
2020
|
|
| 2020
|
Anticholinergic burden among participants in Alzheimer’s clinical trials.
Alzheimer's and Dementia.
16.
2020
|
|
| 2020
|
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
Lancet Neurology.
19:970-971.
2020
|
|
| 2020
|
Comorbidity burden in Alzheimer’s disease clinical trials.
Alzheimer's and Dementia.
16.
2020
|
|
| 2020
|
Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis Complex.
Pediatric Neurology.
113:46-50.
2020
|
|
| 2020
|
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurology.
19:988-997.
2020
|
|
| 2020
|
CTNI-10. MAINTENANCE CHEMOTHERAPY USING BEVACIZUMAB FOR NEUROFIBROMATOSIS 2 PATIENTS WITH HEARING LOSS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (NF104).
Neuro-Oncology.
22:ii43-ii43.
2020
|
|
| 2020
|
A longitudinal study of symptom botheration in Multiple Sclerosis..
Multiple Sclerosis and Related Disorders.
46.
2020
|
|
| 2020
|
CTNI-10. MAINTENANCE CHEMOTHERAPY USING BEVACIZUMAB FOR NEUROFIBROMATOSIS 2 PATIENTS WITH HEARING LOSS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (NF104).
Neuro-Oncology.
22:ii43-ii43.
2020
|
|
| 2020
|
Correction to: “Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective Multicenter Cohort Study of Imaging Selection” (Annals of Neurology, (2020), 87, 3, (419-433), 10.1002/ana.25669).
Annals of Neurology.
88:1056-1057.
2020
|
|
| 2020
|
Effect size – one size doesn't fit all.
Multiple Sclerosis and Related Disorders.
46.
2020
|
|
| 2020
|
Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis.
Multiple Sclerosis and Related Disorders.
46.
2020
|
|
| 2020
|
Timing of initiation of renal-replacement therapy in acute kidney injury.
New England Journal of Medicine.
383:1796.
2020
|
|
| 2020
|
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: A Neurofibromatosis Clinical Trials Consortium study.
Neuro-Oncology.
22:1527-1535.
2020
|
|
| 2020
|
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets
2020
|
|
| 2020
|
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy.
Epilepsy and Behavior.
111.
2020
|
|
| 2020
|
Design and baseline data of a randomized trial comparing two methods for scaling-up an occupational sun protection intervention.
Contemporary Clinical Trials.
97.
2020
|
|
| 2020
|
Gender differences in quality of life among patients with myasthenia gravis in China.
Health and Quality of Life Outcomes.
18.
2020
|
|
| 2020
|
Longitudinal Analysis of Disease Burden in Refractory and Nonrefractory Generalized Myasthenia Gravis in the United States.
Journal of Clinical Neuromuscular Disease.
22:11-21.
2020
|
|
| 2020
|
Sales to apparently alcohol-intoxicated customers and online responsible vendor training in recreational cannabis stores in a randomized trial.
International Journal of Drug Policy.
83.
2020
|
|
| 2020
|
Évaluation des valeurs de l’index des anticorps anti–JCV chez des patients atteints de SEP traités par natalizumab avec une extension de l’intervalle de dose par rapport à l’intervalle de dose standard : une analyse de la base de données TOUCH®.
Revue Neurologique.
176:S125.
2020
|
|
| 2020
|
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Neurology.
95:E755-E766.
2020
|
|
| 2020
|
Ofatumumab versus Teriflunomide in Multiple Sclerosis..
New England Journal of Medicine.
383:546-557.
2020
|
|
| 2020
|
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
Neurology.
95:E446-E456.
2020
|
|
| 2020
|
Aggressive multiple sclerosis (1): Towards a definition of the phenotype
2020
|
|
| 2020
|
Aggressive multiple sclerosis (2): Treatment
2020
|
|
| 2020
|
Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
Muscle and Nerve.
62:261-266.
2020
|
|
| 2020
|
Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis
2020
|
|
| 2020
|
Early Cardiac and Cerebral Hemodynamics with Umbilical Cord Milking Compared with Delayed Cord Clamping in Infants Born Preterm.
Journal of Pediatrics.
223:51-56.e1.
2020
|
|
| 2020
|
Patient-centered outcomes and key study procedure finalization in the pilot feasibility gout randomized trial: Comparative feasibility study in GOUt, CHerry extract versus diet modification (Mini-GOUCH)
2020
|
|
| 2020
|
Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex.
Pediatric Neurology.
109:39-46.
2020
|
|
| 2020
|
Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis
2020
|
|
| 2020
|
Reply to: Exercise for “Sleep Rehabilitation” in Parkinson's Disease.
Movement Disorders.
35:1286.
2020
|
|
| 2020
|
Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise.
Cell.
181:1464-1474.
2020
|
|
| 2020
|
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout
2020
|
|
| 2020
|
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.
2020
|
|
| 2020
|
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease.
Movement Disorders.
35:947-958.
2020
|
|
| 2020
|
Study protocol: Improving cognition in people with progressive multiple sclerosis: A multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx).
BMC Neurology.
20.
2020
|
|
| 2020
|
Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD.
Multiple Sclerosis and Related Disorders.
40.
2020
|
|
| 2020
|
Association of Umbilical Cord Milking vs Delayed Umbilical Cord Clamping with Death or Severe Intraventricular Hemorrhage among Preterm Infants.
Obstetrical and Gynecological Survey.
75:212-214.
2020
|
|
| 2020
|
Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.
Neurology.
94:495-500.
2020
|
|
| 2020
|
Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging Selection.
Annals of Neurology.
87:419-433.
2020
|
|
| 2020
|
EFFECT size or statistical significance, where to put your money.
Multiple Sclerosis and Related Disorders.
38.
2020
|
|
| 2020
|
Using practice effects for targeted trials or sub-group analysis in Alzheimer’s disease: How practice effects predict change over time.
PLoS One.
15.
2020
|
|
| 2020
|
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1.
Annals of Clinical and Translational Neurology.
7:245-249.
2020
|
|
| 2020
|
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials.
Therapeutic Advances in Neurological Disorders.
13.
2020
|
|
| 2020
|
Feasibility of “Sit Less, Move More”: An intervention for reducing sedentary behavior Among African Americans with MS.
Multiple Sclerosis Journal - Experimental, Translational and Clinical.
6.
2020
|
|
| 2020
|
Fertility restoration of maize CMS-C altered by a single amino acid substitution within the Rf4 bHLH transcription factor
2020
|
|
| 2020
|
Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis.
Multiple Sclerosis and Related Disorders.
37.
2020
|
|
| 2020
|
Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative.
Journal of Alzheimer's Disease.
76:691-701.
2020
|
|
| 2020
|
Rett syndrome: Novel correlations linking >96% genotype, disease severity, and seizures
2020
|
|
| 2019
|
Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder.
Journal of Neurodevelopmental Disorders.
11.
2019
|
|
| 2019
|
199 Changes in natalizumab exposure and PML incidence over time.
Journal of Neurology, Neurosurgery and Psychiatry.
90:e50.
2019
|
|
| 2019
|
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
Muscle and Nerve.
60:707-715.
2019
|
|
| 2019
|
Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis.
Muscle and Nerve.
60:700-706.
2019
|
|
| 2019
|
Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis.
Contemporary Clinical Trials.
87.
2019
|
|
| 2019
|
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1.
Annals of Clinical and Translational Neurology.
6:2555-2565.
2019
|
|
| 2019
|
Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study.
Epilepsia.
60:2428-2436.
2019
|
|
| 2019
|
Association of umbilical cord milking vs delayed umbilical cord clamping with death or severe intraventricular hemorrhage among preterm infants.
Journal of the American Medical Association.
322:1877-1886.
2019
|
|
| 2019
|
ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL.
Neuro-Oncology.
21:vi8-vi8.
2019
|
|
| 2019
|
ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL.
Neuro-Oncology.
21:vi8-vi8.
2019
|
|
| 2019
|
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
2019
|
|
| 2019
|
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing.
Neurology.
93:e1452-e1462.
2019
|
|
| 2019
|
Functional gastrointestinal disorders negatively affect health-related quality of life in MS.
Neurology: Clinical Practice.
9:381-390.
2019
|
|
| 2019
|
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients with Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study.
JAMA Neurology.
76:1147-1156.
2019
|
|
| 2019
|
The Virtual Short Physical Performance Battery: Psychometric Properties and Validation in Older Adults With Multiple Sclerosis.
Journal of Applied Gerontology.
38:1492-1505.
2019
|
|
| 2019
|
Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.
Epilepsy and Behavior.
98:201-206.
2019
|
|
| 2019
|
Early complement genes are associated with visual system degeneration in multiple sclerosis
2019
|
|
| 2019
|
Biogeochemical controls of surface ocean phosphate.
Science Advances.
5.
2019
|
|
| 2019
|
Video telehealth pulmonary rehabilitation intervention in chronic obstructive pulmonary disease reduces 30-day readmissions.
American Journal of Respiratory and Critical Care Medicine.
200:511-513.
2019
|
|
| 2019
|
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy.
Epilepsy and Behavior.
97:105-110.
2019
|
|
| 2019
|
Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS.
Multiple Sclerosis and Related Disorders.
33:13-21.
2019
|
|
| 2019
|
Quality of Care for Veterans With In-Hospital Stroke..
Federal practitioner : for the health care professionals of the VA, DoD, and PHS.
36:365-369.
2019
|
|
| 2019
|
Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial.
Cancer Research.
79:ct233-ct233.
2019
|
|
| 2019
|
Examining the impact of refractory myasthenia gravis on healthcare resource utilization in the United States: Analysis of a myasthenia gravis foundation of america patient registry sample
2019
|
|
| 2019
|
O1‐09‐03: SEX IS NOT AN IMPORTANT PREDICTOR OF CHANGE IN ALZHEIMER'S CLINICAL TRIAL OUTCOMES.
Alzheimer's and Dementia.
15:p217-p218.
2019
|
|
| 2019
|
P3‐548: PROGRESSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE IN CANCER SURVIVORS.
Alzheimer's and Dementia.
15:p1183-p1183.
2019
|
|
| 2019
|
Tuberous Sclerosis Complex Genotypes and Developmental Phenotype.
Pediatric Neurology.
96:58-63.
2019
|
|
| 2019
|
Cortical Activation Elicited by Subthalamic Deep Brain Stimulation Predicts Postoperative Motor Side Effects.
Neuromodulation.
22:456-464.
2019
|
|
| 2019
|
Evaluation of a web-based fall prevention program among people with multiple sclerosis.
Multiple Sclerosis and Related Disorders.
31:151-156.
2019
|
|
| 2019
|
Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life.
Journal of Clinical Neuromuscular Disease.
20:173-181.
2019
|
|
| 2019
|
Implementation of Occupational Sun Safety at a 2-Year Follow-Up in a Randomized Trial: Comparison of Sun Safe Workplaces Policy Intervention to Attention Control.
American Journal of Health Promotion.
33:683-697.
2019
|
|
| 2019
|
Multiple sclerosis: Clinical trial design 2019.
Current Opinion in Neurology.
32:358-364.
2019
|
|
| 2019
|
Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple Sclerosis.
Contemporary Clinical Trials.
81:110-122.
2019
|
|
| 2019
|
The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments.
Multiple Sclerosis and Related Disorders.
31:165-172.
2019
|
|
| 2019
|
Hand stereotypies: Lessons from the Rett Syndrome Natural History Study.
Neurology.
92:E2594-E2603.
2019
|
|
| 2019
|
The Emerging Gait Dysfunction Phenotype in Idiopathic Parkinson’s Disease
2019
|
|
| 2019
|
An intervention for changing sedentary behavior among African Americans with multiple sclerosis: Protocol.
JMIR Research Protocols.
8.
2019
|
|
| 2019
|
Clinical trials in multiple sclerosis: potential future trial designs.
Therapeutic Advances in Neurological Disorders.
12.
2019
|
|
| 2019
|
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b
2019
|
|
| 2019
|
Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration.
American Psychologist.
74:356-367.
2019
|
|
| 2019
|
Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time.
Revue Neurologique.
175:s96-s97.
2019
|
|
| 2019
|
Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program.
Revue Neurologique.
175:s102.
2019
|
|
| 2019
|
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.
Multiple Sclerosis and Related Disorders.
29:86-93.
2019
|
|
| 2019
|
A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS.
Neurology.
92:469-480.
2019
|
|
| 2019
|
The prevalence of MS in the United States: A population-based estimate using health claims data.
Neurology.
92:E1029-E1040.
2019
|
|
| 2019
|
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
Lancet Neurology.
18:259-268.
2019
|
|
| 2019
|
Abstract 111: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core and Early Presentation.
Stroke.
50.
2019
|
|
| 2019
|
Abstract 164: Early Infarct Growth Correlates With Both Collateral Status and Clinical Outcomes After Thrombecomy.
Stroke.
50.
2019
|
|
| 2019
|
Abstract 4: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core Lesions on Either Simple CT or Perfusion Images.
Stroke.
50.
2019
|
|
| 2019
|
Abstract TMP16: IV tPA Does Not Delay Endovascular Thrombectomy and is Associated With Improved Clinical Outcomes.
Stroke.
50.
2019
|
|
| 2019
|
Abstract WMP9: Does Repeat Images Improve Patient Selection and Clinical Outcomes in Patients Transferred for Endovascular Thrombectomy?.
Stroke.
50.
2019
|
|
| 2019
|
Abstract WP75: Ischemic Core Volume Modifies the Association Between ASPECT Score and Clinical Outcome.
Stroke.
50.
2019
|
|
| 2019
|
Evolution of clinical trials in multiple sclerosis.
Therapeutic Advances in Neurological Disorders.
12.
2019
|
|
| 2019
|
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Muscle and Nerve.
59:201-207.
2019
|
|
| 2019
|
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients.
Pediatric Transplantation.
23.
2019
|
|
| 2019
|
Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex.
Epilepsia.
60:1721-1732.
2019
|
|
| 2019
|
LB 1: Premature Infants Receiving Cord Milking or Delayed Cord Clamping: A Randomized Controlled Non-inferiority Trial.
American Journal of Obstetrics and Gynecology.
220:s682.
2019
|
|
| 2019
|
Multicenter, prospective, phase II and biomarker study of high-dose bevacizumab as induction therapy in patients with neurofibromatosis type 2 and progressive vestibular schwannoma.
Journal of Clinical Oncology.
37:3446-3454.
2019
|
|
| 2019
|
Use of eHealth and mHealth technology by persons with multiple sclerosis.
Multiple Sclerosis and Related Disorders.
27:13-19.
2019
|
|
| 2018
|
A randomized, controlled pilot trial of the Emotional Faces Memory Task: a digital therapeutic for depression.
npj Digital Medicine.
1.
2018
|
|
| 2018
|
High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
Journal of epilepsy.
148:1-7.
2018
|
|
| 2018
|
Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical Trials.
Archives of Physical Medicine and Rehabilitation.
99:2637-2648.
2018
|
|
| 2018
|
Pseudobulbar affect prevalence and association with symptoms inmultiple sclerosis.
Neurology: Clinical Practice.
8:472-481.
2018
|
|
| 2018
|
Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis.
BMJ Open.
8.
2018
|
|
| 2018
|
An Intervention for Changing Sedentary Behavior Among African Americans With Multiple Sclerosis: Protocol (Preprint)
2018
|
|
| 2018
|
Association of Concomitant Use of Cholinesterase Inhibitors or Memantine with Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.
JAMA Network Open.
1.
2018
|
|
| 2018
|
Gender differences in prednisone adverse effects Survey result from the MG registry
2018
|
|
| 2018
|
Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.
Arthritis Care and Research.
70:1653-1660.
2018
|
|
| 2018
|
Divergent effects of AKI to CKD models on inflammation and fibrosis
2018
|
|
| 2018
|
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.
Epilepsy and Behavior.
87:131-136.
2018
|
|
| 2018
|
PND93 - THE IMPACT OF MYASTHENIA GRAVIS (MG) ON HEALTHCARE RESOURCE UTILIZATION: EMPIRICAL EVIDENCE FROM A US REGISTRY SAMPLE.
Value in Health.
21:s344.
2018
|
|
| 2018
|
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
2018
|
|
| 2018
|
An introduction to Mendelian randomization with applications in neurology.
Multiple Sclerosis and Related Disorders.
24:72-78.
2018
|
|
| 2018
|
Phase-III, randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis: Project BIPAMS.
Contemporary Clinical Trials.
71:154-161.
2018
|
|
| 2018
|
Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry.
Muscle and Nerve.
58:90-98.
2018
|
|
| 2018
|
Mortality in neuromyelitis optica is strongly associated with African ancestry
2018
|
|
| 2018
|
P4‐015: RACIAL AND ETHNIC DIFFERENCES IN CONCOMITANT USE OF CHOLINESTERASE INHIBITORS AND MEMANTINE IN ALZHEIMER'S CLINICAL TRIALS.
Alzheimer's and Dementia.
14:p1437-p1437.
2018
|
|
| 2018
|
NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDY.
Neuro-Oncology.
20:i142-i142.
2018
|
|
| 2018
|
NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY.
Neuro-Oncology.
20:i143-i143.
2018
|
|
| 2018
|
NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY.
Neuro-Oncology.
20:i144-i144.
2018
|
|
| 2018
|
071 Natalizumab extended interval dosing (EID) is associated with a significant reduction in progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the touch® prescribing program.
Journal of Neurology, Neurosurgery and Psychiatry.
89:a29.
2018
|
|
| 2018
|
A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry
2018
|
|
| 2018
|
Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution.
PLoS One.
13.
2018
|
|
| 2018
|
NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDY.
Neuro-Oncology.
20:i142-i142.
2018
|
|
| 2018
|
NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY.
Neuro-Oncology.
20:i143-i143.
2018
|
|
| 2018
|
NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY.
Neuro-Oncology.
20:i144-i144.
2018
|
|
| 2018
|
Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study..
Journal of Clinical Oncology.
36:2056-2056.
2018
|
|
| 2018
|
A survey of dietary characteristics in a large population of people with multiple sclerosis.
Multiple Sclerosis and Related Disorders.
22:12-18.
2018
|
|
| 2018
|
Results of a Randomized Trial on an Intervention Promoting Adoption of Occupational Sun Protection Policies.
American Journal of Health Promotion.
32:1042-1053.
2018
|
|
| 2018
|
Cerebellar volume as an imaging marker of development in infants with tuberous sclerosis complex..
Neurology.
90:e1493-e1500.
2018
|
|
| 2018
|
Factors associated with excessive sitting time in multiple sclerosis.
Multiple Sclerosis and Related Disorders.
21:71-77.
2018
|
|
| 2018
|
Declining Financial Capacity in Mild Cognitive Impairment: A Six-Year Longitudinal Study.
Archives of Clinical Neuropsychology.
34:152-161.
2018
|
|
| 2018
|
Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE
2018
|
|
| 2018
|
Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function.
Neurorehabilitation and Neural Repair.
32:223-232.
2018
|
|
| 2018
|
Understanding and preventing loss to follow-up: Experiences from the spinal cord injury model systems.
Topics in Spinal Cord Injury Rehabilitation.
24:97-109.
2018
|
|
| 2018
|
Accuracy of blood pressure measurement devices in pregnancy: A systematic review of validation studies.
Hypertension.
71:326-335.
2018
|
|
| 2018
|
Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis.
Multiple Sclerosis and Related Disorders.
20:16-21.
2018
|
|
| 2018
|
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
Pongkiat Kankirawatana, Dr Rani Singh, Professor David G Standaert, Dr Yuliang Liu, Dr Leon Dure, Dr Jennifer DeWollfe, Professor Gary Cutter, Dr Tyler Gaston, Dr Ashley Thomas, Professor E. Martina Bebin, Dr. Lawrence Ver Hoef.
Epilepsy and Behavior.
(in press).
2018
|
|
| 2018
|
Clinical trials in multiple sclerosis: milestones.
Therapeutic Advances in Neurological Disorders.
11.
2018
|
|
| 2018
|
Diet quality is associated with disability and symptom severity in multiple sclerosis.
Neurology.
90:E1-E11.
2018
|
|
| 2018
|
DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial..
Open Heart.
5:e000780.
2018
|
|
| 2018
|
Learning from the past: Reflections on recently completed myasthenia gravis trials.
Annals of the New York Academy of Sciences.
1412:5-13.
2018
|
|
| 2018
|
National estimates of self-reported sitting time in adults with multiple sclerosis.
Multiple Sclerosis Journal - Experimental, Translational and Clinical.
4.
2018
|
|
| 2018
|
Neurofibromatosis Clinical Trial Consortium.
Journal of Child Neurology.
33:82-91.
2018
|
|
| 2018
|
Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era.
Therapeutic Advances in Neurological Disorders.
11.
2018
|
|
| 2018
|
Sun safe workplaces: Effect of an occupational skin cancer prevention program on employee sun safety practices.
Journal of Occupational and Environmental Medicine.
60:990-997.
2018
|
|
| 2017
|
A Randomized Trial of an Advanced Sun Safety Intervention for Vacationers at 41 North American Resorts
2017
|
|
| 2017
|
Pedestrian safety in patients with Parkinson's disease: A case-control study.
Movement Disorders.
32:1748-1755.
2017
|
|
| 2017
|
Presentation and diagnosis of tuberous sclerosis complex in infants.
Pediatrics.
140.
2017
|
|
| 2017
|
RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY.
Neuro-Oncology.
19:vi215-vi215.
2017
|
|
| 2017
|
Cell-based therapeutic strategies for multiple sclerosis.
2017
|
|
| 2017
|
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years.
Multiple Sclerosis and Related Disorders.
18:95-102.
2017
|
|
| 2017
|
RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY.
Neuro-Oncology.
19:vi215-vi215.
2017
|
|
| 2017
|
Correction to: Prevalence odds ratio versus prevalence ratio: choice comes with consequences: Prevalence odds ratio versus prevalence ratio (Statistics in Medicine, (2016), 35, 30, (5730-5735), 10.1002/sim.7059).
Statistics in Medicine.
36:3760.
2017
|
|
| 2017
|
Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
American Journal of Geriatric Psychiatry.
25:1150-1159.
2017
|
|
| 2017
|
Clinical trial design for progressive MS trials
2017
|
|
| 2017
|
The Clinical Impact of Daptomycin Non-susceptible Enterococcus Bacteremia in Hematologic Malignancy.
Open Forum Infectious Diseases.
4:s289-s289.
2017
|
|
| 2017
|
Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex.
Pediatric Neurology.
75:80-86.
2017
|
|
| 2017
|
Author response: High hypothetical interest in physician-assisted death in multiple sclerosis.
Neurology.
89:1429-1430.
2017
|
|
| 2017
|
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.
Pediatric Nephrology.
32:1565-1573.
2017
|
|
| 2017
|
Interactions between cannabidiol and commonly used antiepileptic drugs.
Epilepsia.
58:1586-1592.
2017
|
|
| 2017
|
Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?.
Multiple Sclerosis Journal - Experimental, Translational and Clinical.
3.
2017
|
|
| 2017
|
Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease.
Journal of Neuroimmunology.
309:100-110.
2017
|
|
| 2017
|
Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
Osteoporosis International.
28:2495-2503.
2017
|
|
| 2017
|
Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5).
Osteoporosis International.
28:2505.
2017
|
|
| 2017
|
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants.
Neurology: Clinical Practice.
7:333-343.
2017
|
|
| 2017
|
Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology.
Annals of Clinical and Translational Neurology.
4:466-477.
2017
|
|
| 2017
|
[O4–03–05]: CONCOMITANT USE OF CHOLINESTERASE INHIBITORS OR MEMANTINE IS ASSOCIATED WITH COGNITIVE DECLINE IN ALZHEIMER's CLINICAL TRIALS.
Alzheimer's and Dementia.
13:p1234-p1234.
2017
|
|
| 2017
|
Adjunctive Azithromycin Prophylaxis for Cesarean Delivery
2017
|
|
| 2017
|
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note
2017
|
|
| 2017
|
Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: Results of a matching-adjusted indirect comparison.
Journal of Comparative Effectiveness Research.
6:313-323.
2017
|
|
| 2017
|
Effect of an intervention on observed sun protection by vacationers in a randomized controlled trial at North American resorts.
Preventive Medicine.
99:29-36.
2017
|
|
| 2017
|
Employment and absenteeism in working-age persons with multiple sclerosis
2017
|
|
| 2017
|
Influence of seizures on early development in tuberous sclerosis complex..
Epilepsy and Behavior.
70:245-252.
2017
|
|
| 2017
|
Publication outcomes of abstracts from the American Society of Hematology Annual Meeting.
American Journal of Hematology.
92:E81-E83.
2017
|
|
| 2017
|
The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease.
Brain Stimulation.
10:651-656.
2017
|
|
| 2017
|
High hypothetical interest in physician-assisted death in multiple sclerosis.
Neurology.
88:1528-1534.
2017
|
|
| 2017
|
Assessment of Caregiver Inventory for Rett Syndrome.
Journal of Autism and Developmental Disorders.
47:1102-1112.
2017
|
|
| 2017
|
Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple Sclerosis.
Research in Nursing and Health.
40:143-152.
2017
|
|
| 2017
|
Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis.
Multiple Sclerosis and Related Disorders.
13:87-92.
2017
|
|
| 2017
|
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification.
Neurology.
88:1197-1205.
2017
|
|
| 2017
|
Prevalence of Sun Protection at Outdoor Recreation and Leisure Venues at Resorts in North America.
American Journal of Health Education.
48:90-99.
2017
|
|
| 2017
|
Association between early childhood caries and colonization with streptococcus mutans genotypes from mothers.
Pediatric Dentistry.
39:130-135.
2017
|
|
| 2017
|
Effects of Subthalamic Nucleus Deep Brain Stimulation on Objective Sleep Outcomes in Parkinson's Disease.
Movement Disorders Clinical Practice.
4:183-190.
2017
|
|
| 2017
|
Continuous electroencephalography (cEEG) monitoring and outcomes of critically Ill patients
2017
|
|
| 2017
|
Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.
Obstetrical and Gynecological Survey.
72:71-73.
2017
|
|
| 2017
|
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses.
Multiple Sclerosis and Related Disorders.
12:70-78.
2017
|
|
| 2017
|
A framework of care in multiple sclerosis, part 2: Symptomatic care and beyond.
International Journal of MS Care.
19:42-56.
2017
|
|
| 2017
|
Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set
2017
|
|
| 2017
|
Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive Impairment
2017
|
|
| 2017
|
Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosis.
International Journal of MS Care.
19:240-246.
2017
|
|
| 2016
|
Prevalence odds ratio versus prevalence ratio: choice comes with consequences.
Statistics in Medicine.
35:5730-5735.
2016
|
|
| 2016
|
Clinical trials: To catch a crook, you might try statistics.
Nature Reviews Neurology.
13:9-10.
2016
|
|
| 2016
|
Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.
Neurology.
87:2575-2584.
2016
|
|
| 2016
|
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.
Muscle and Nerve.
54:1015-1022.
2016
|
|
| 2016
|
Sustained High Level of Healthcare Worker Adherence with Hand Hygiene Practice Recommendations Using the Patient-as-Observer Approach in the Ambulatory Setting.
Infection Control and Hospital Epidemiology.
37:1496-1498.
2016
|
|
| 2016
|
The authors reply.
New England Journal of Medicine.
375:2006-2007.
2016
|
|
| 2016
|
Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS.
Neurology: Clinical Practice.
6:397-408.
2016
|
|
| 2016
|
Long-term evolution of multiple sclerosis disability in the treatment era.
Annals of Neurology.
80:499-510.
2016
|
|
| 2016
|
Adjunctive azithromycin prophylaxis for cesarean delivery.
New England Journal of Medicine.
375:1231-1241.
2016
|
|
| 2016
|
Laquinimod efficacy in relapsing-remitting multiple sclerosis: How to understand why and if studies disagree.
BMC Neurology.
16.
2016
|
|
| 2016
|
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
Journal of Neuroimmunology.
297:1-8.
2016
|
|
| 2016
|
Randomized trial of thymectomy in myasthenia gravis.
New England Journal of Medicine.
375:511-522.
2016
|
|
| 2016
|
Health insurance affects the use of disease-modifying therapy in multiple sclerosis.
Neurology.
87:365-374.
2016
|
|
| 2016
|
Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?
2016
|
|
| 2016
|
O4‐05‐06: Limitations of the Fda‐Approved ‘Ad Clinical Trial Simulation Tool’.
Alzheimer's and Dementia.
12:p344-p344.
2016
|
|
| 2016
|
P3‐012: Advancing Therapeutics for Neuroinflammation in Alzheimer's Disease: Clinical Development Considerations.
Alzheimer's and Dementia.
12:p822-p822.
2016
|
|
| 2016
|
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.
Journal of the Neurological Sciences.
365:190-198.
2016
|
|
| 2016
|
Placebo-controlled study in neuromyelitis optica - Ethical and design considerations
2016
|
|
| 2016
|
Rigorous control conditions diminish treatment effects in weight loss-randomized controlled trials.
International Journal of Obesity.
40:895-898.
2016
|
|
| 2016
|
Analysis of diagnoses associated with multiple sclerosis-related in-hospital mortality using the premier hospital database.
International Journal of MS Care.
18:154-161.
2016
|
|
| 2016
|
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
Journal of Neuroimaging.
26:296-302.
2016
|
|
| 2016
|
Statistical Considerations for an Adaptive Design for a Serious Rare Disease.
Therapeutic Innovation & Regulatory Science.
50:375-384.
2016
|
|
| 2016
|
Recommendations for observational studies of comorbidity in multiple sclerosis..
Neurology.
86:1446-1453.
2016
|
|
| 2016
|
The challenge of comorbidity in clinical trials for multiple sclerosis..
Neurology.
86:1437-1445.
2016
|
|
| 2016
|
Long-term registries.
Neurology: Clinical Practice.
6:97-99.
2016
|
|
| 2016
|
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Journal of the Neurological Sciences.
362:121-126.
2016
|
|
| 2016
|
Relapses in multiple sclerosis: Relationship to disability.
Multiple Sclerosis and Related Disorders.
6:10-20.
2016
|
|
| 2016
|
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
Journal of Alzheimer's Disease.
50:1205-1215.
2016
|
|
| 2016
|
Extended interval dosing of natalizumab in multiple sclerosis.
Journal of Neurology, Neurosurgery and Psychiatry.
87:885-889.
2016
|
|
| 2016
|
3: Azithromycin-based extended spectrum antibiotic prophylaxis for non-elective cesarean delivery: a pragmatic multicenter placebo-controlled double-blind rct.
American Journal of Obstetrics and Gynecology.
214:s3.
2016
|
|
| 2016
|
A framework of care in multiple sclerosis, part 1: Updated disease classification and disease-modifying therapy use in specific circumstances.
International Journal of MS Care.
18:314-323.
2016
|
|
| 2016
|
Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants.
Pediatric Neurology.
54:29-34.
2016
|
|
| 2016
|
Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center.
Journal of Hospital Medicine.
11:15-20.
2016
|
|
| 2016
|
Maternal BMI Associations with Maternal and Cord Blood Vitamin D Levels in a North American Subset of Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Participants..
PLoS One.
11:e0150221.
2016
|
|
| 2016
|
Pooling Morphometric Estimates: A Statistical Equivalence Approach.
Journal of Neuroimaging.
26:109-115.
2016
|
|
| 2016
|
Randomized trial of thymectomy in myasthenia gravis.
Journal of Thoracic Disease.
8:E1782-E1783.
2016
|
|
| 2016
|
Rationale, design, samples, and baseline sun protection in a randomized trial on a skin cancer prevention intervention in resort environments.
Contemporary Clinical Trials.
46:67-76.
2016
|
|
| 2015
|
Prevalence and incidence of early childhood caries among African-American children in Alabama.
Journal of Public Health Dentistry.
75:42-48.
2015
|
|
| 2015
|
Sustained use of an occupational sun safety program in a recreation industry: follow-up to a randomized trial on dissemination strategies.
Translational Behavioral Medicine.
5:361-371.
2015
|
|
| 2015
|
Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov.
Clinical Trials.
12:575-583.
2015
|
|
| 2015
|
Abstract 19094: Use of ACE Inhibitors or Angiotensin Receptor Blockers is Associated With a Significantly Lower Risk of 30-day All-cause and Heart Failure Readmissions and All-cause Mortality in Older Medicare Beneficiaries Hospitalized for Heart Failure Developing Acute Kidney Injury.
Circulation.
132.
2015
|
|
| 2015
|
Capacity of patients with brain metastases to make treatment decisions
2015
|
|
| 2015
|
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis..
Value in Health.
18:A750.
2015
|
|
| 2015
|
Defining reliable disability outcomes in multiple sclerosis
2015
|
|
| 2015
|
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Multiple Sclerosis and Related Disorders.
4:546-554.
2015
|
|
| 2015
|
Two-group time-to-event continual reassessment method using likelihood estimation.
Contemporary Clinical Trials.
45:340-345.
2015
|
|
| 2015
|
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment
2015
|
|
| 2015
|
Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?
2015
|
|
| 2015
|
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Human Brain Mapping.
36:3749-3760.
2015
|
|
| 2015
|
Causes of death among persons with multiple sclerosis.
Multiple Sclerosis and Related Disorders.
4:484-490.
2015
|
|
| 2015
|
Factors associated with early childhood caries incidence among high caries-risk children.
Community Dentistry and Oral Epidemiology.
43:366-374.
2015
|
|
| 2015
|
Pooling morphometric estimates: a statistical equivalence approach
2015
|
|
| 2015
|
VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts.
Journal of Rehabilitation Research and Development.
52:263-272.
2015
|
|
| 2015
|
Translation of a Ski School Sun Safety Program to North American Ski and Snowboard Schools.
Health Promotion Practice.
16:560-570.
2015
|
|
| 2015
|
O1‐10‐02: How does differential effect of treatment in ApoE‐ɛ4+ carriers change clinical trial design in Alzheimer's disease?.
Alzheimer's and Dementia.
11:p154-p154.
2015
|
|
| 2015
|
To treat or not to treat, that really is not the question.
Neurology: Clinical Practice.
5:253-258.
2015
|
|
| 2015
|
The promise of futility trials in neurological diseases.
Nature Reviews Neurology.
11:300-305.
2015
|
|
| 2015
|
Impact of multiple sclerosis relapse: The NARCOMS participant perspective.
Multiple Sclerosis and Related Disorders.
4:234-240.
2015
|
|
| 2015
|
Multiple sclerosis drugs: How much bang for the buck?.
Lancet Neurology.
14:460-461.
2015
|
|
| 2015
|
Risk tolerance to MS therapies: Survey results from the NARCOMS registry.
Multiple Sclerosis and Related Disorders.
4:241-249.
2015
|
|
| 2015
|
Marijuana Usage and Disability in MS in the NARCOMS Registry.
Neurology.
April 06, 2015; 84 (14 Supplement):P1.140-P1.140.
2015
|
|
| 2015
|
Differences in Alzheimer disease clinical trial outcomes based on age of the participants.
Neurology.
84:1121-1127.
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of cancer in multiple sclerosis
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis
2015
|
|
| 2015
|
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review
2015
|
|
| 2015
|
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
2015
|
|
| 2015
|
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Contemporary Clinical Trials.
41:69-74.
2015
|
|
| 2015
|
Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center data.
Multiple Sclerosis and Related Disorders.
4:124-136.
2015
|
|
| 2015
|
Abstract W P270: Quality of In-Hospital Stroke Care in Veterans Affairs Hospitals.
Stroke.
46.
2015
|
|
| 2015
|
A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy Controls.
NeuroInformatics.
13:7-18.
2015
|
|
| 2015
|
Care partners and multiple sclerosis: Differential effect on men and women.
International Journal of MS Care.
17:253-260.
2015
|
|
| 2015
|
Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: A cross-sectional survey.
BMJ Open.
5.
2015
|
|
| 2015
|
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.
Neurodegenerative Disease Management.
5:3-10.
2015
|
|
| 2015
|
The sustainability of an occupational skin cancer prevention program.
Journal of Occupational and Environmental Medicine.
57:1207-1213.
2015
|
|
| 2014
|
Chronobiology of Hypertension in Sickle Cell Disease.
Blood.
124:4094-4094.
2014
|
|
| 2014
|
Distinct populations of label-retaining cells in the adult kidney are defined temporally and exhibit divergent regional distributions
2014
|
|
| 2014
|
Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns.
Journal of Pediatrics.
165:1104-1108.e1.
2014
|
|
| 2014
|
Pubertal development in rett syndrome deviates from typical females.
Pediatric Neurology.
51:769-775.
2014
|
|
| 2014
|
No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis.
Advances in Therapy.
31:1134-1154.
2014
|
|
| 2014
|
Composite end points to assess delay of disability progression by MS treatments
2014
|
|
| 2014
|
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
BMC Neurology.
14.
2014
|
|
| 2014
|
Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.
Journal of Infectious Diseases.
210:1155-1165.
2014
|
|
| 2014
|
Cognition in patients with newly diagnosed brain metastasis: Profiles and implications.
Journal of Neuro-Oncology.
120:179-185.
2014
|
|
| 2014
|
A-75Financial Decline in Patients with Mild Cognitive Impairment: A Six-year Longitudinal Study.
Archives of Clinical Neuropsychology.
29:530-531.
2014
|
|
| 2014
|
Abstract 327: The Choice of Diuretic is Important in the Treatment of Resistant Hypertension.
Hypertension.
64.
2014
|
|
| 2014
|
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
2014
|
|
| 2014
|
Causes of death among commercially insured multiple sclerosis patients in the United States.
PLoS One.
9.
2014
|
|
| 2014
|
Defining the clinical course of multiple sclerosis: The 2013 revisions.
Neurology.
83:278-286.
2014
|
|
| 2014
|
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.
Patient Preference and Adherence.
8:971-979.
2014
|
|
| 2014
|
P2‐393: THE USE OF META‐DATABASE DATA FOR QUALITY CONTROL IN CLINICAL TRIALS: AN EXAMPLE USING THE MMSE.
Alzheimer's and Dementia.
10:p623-p623.
2014
|
|
| 2014
|
P4‐176: DIFFERENCES IN ALZHEIMER DISEASE CLINICAL TRIALS OUTCOMES BASED ON AGE OF PATIENTS.
Alzheimer's and Dementia.
10:p853-p853.
2014
|
|
| 2014
|
P4‐177: BASELINE COGNITIVE SEVERITY DOES NOT PREDICT RATE OF CHANGE IN THE ADAS‐COG CLINICAL TRIALS.
Alzheimer's and Dementia.
10:p853-p854.
2014
|
|
| 2014
|
Bifactor structure of clinical disability in relapsing multiple sclerosis.
Multiple Sclerosis and Related Disorders.
3:176-185.
2014
|
|
| 2014
|
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial..
Lancet Neurology.
13:247-256.
2014
|
|
| 2014
|
Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference..
Kidney International.
85:513-521.
2014
|
|
| 2014
|
Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services.
Journal of Public Health Management and Practice.
20.
2014
|
|
| 2014
|
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.
American Journal of Medicine.
127:132-139.
2014
|
|
| 2014
|
Clinical trials in multiple sclerosis.
Handbook of Clinical Neurology.
122:445-453.
2014
|
|
| 2014
|
Dissemination of go sun smart in outdoor recreation: effect of program exposure on sun protection of guests at high-altitude ski areas.
2014
|
|
| 2014
|
Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?.
Muscle and Nerve.
49:483-486.
2014
|
|
| 2014
|
Does natalizumab therapy benefit patients with multiple sclerosis?.
JAMA Neurology.
71:945-946.
2014
|
|
| 2014
|
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: A randomised, double-blind, placebo-controlled phase 2 clinical trial
2014
|
|
| 2014
|
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
Alzheimer's and Dementia.
10:349-359.
2014
|
|
| 2014
|
Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.
Journal of Pediatrics.
164:744-748.
2014
|
|
| 2014
|
Health literacy association with health behaviors and health care utilization in multiple sclerosis: A cross-sectional study
2014
|
|
| 2014
|
Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab.
Multiple Sclerosis and Related Disorders.
3:505-512.
2014
|
|
| 2014
|
In reply.
JAMA Psychiatry.
71:339-340.
2014
|
|
| 2014
|
Intensive care unit readmission during childhood after preterm birth with respiratory failure.
Journal of Pediatrics.
164.
2014
|
|
| 2014
|
Mutans streptococci enumeration and genotype selection using different bacitracin-containing media.
Journal of Microbiological Methods.
103:53-57.
2014
|
|
| 2014
|
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
Multiple Sclerosis and Related Disorders.
3:705-711.
2014
|
|
| 2014
|
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
Clinical Trials.
11:159-166.
2014
|
|
| 2014
|
Seabed classification using surface backscattering strength versus acoustic frequency and incidence angle measured with vertical, split-beam echosounders
2014
|
|
| 2014
|
Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S..
Multiple Sclerosis and Related Disorders.
3:364-371.
2014
|
|
| 2013
|
Natural history of multiple sclerosis symptoms.
International Journal of MS Care.
15:146-158.
2013
|
|
| 2013
|
Sampling selectivity in acoustic-trawl surveys of Pacific sardine (Sardinops sagax) biomass and length distribution
2013
|
|
| 2013
|
Cost-effectiveness analyses Beauty and the beast?.
Neurology: Clinical Practice.
3:436-439.
2013
|
|
| 2013
|
Establishing the burden of Carbon monoxide exposure in private homes
2013
|
|
| 2013
|
Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population.
Amyotrophic lateral sclerosis & frontotemporal degeneration.
14:334-337.
2013
|
|
| 2013
|
Mortality in patients with multiple sclerosis.
Neurology.
81:184-192.
2013
|
|
| 2013
|
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.
Muscle and Nerve.
48:76-84.
2013
|
|
| 2013
|
MRI lesions: A surrogate for relapses in multiple sclerosis?.
Lancet Neurology.
12:628-630.
2013
|
|
| 2013
|
O4–05–06: Effect of sample size re‐estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment.
Alzheimer's and Dementia.
9:p691-p691.
2013
|
|
| 2013
|
P1–360: Effect of APOE genotype on clinical trial outcomes.
Alzheimer's and Dementia.
9:p290-p290.
2013
|
|
| 2013
|
Characteristics of Streptococcus mutans genotypes and dental caries in children.
European Journal of Oral Sciences.
121:148-155.
2013
|
|
| 2013
|
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis..
Annals of Neurology.
73:705-713.
2013
|
|
| 2013
|
Genomic Copy Number Variants: Evidence for Association with Antibody Response to Anthrax Vaccine Adsorbed.
PLoS One.
8.
2013
|
|
| 2013
|
Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972)).
BMJ Open.
3.
2013
|
|
| 2013
|
Outcomes of screening mammography by frequency, breast density, postmenopausal hormone therapy.
JAMA Internal Medicine.
173:807-816.
2013
|
|
| 2013
|
Constraint-induced movement therapy for the lower extremities in multiple sclerosis: Case series with 4-year follow-up.
Archives of Physical Medicine and Rehabilitation.
94:753-760.
2013
|
|
| 2013
|
Disability in multiple sclerosis: A reference for patients and clinicians.
Neurology.
80:1018-1024.
2013
|
|
| 2013
|
Randomized study combining interferon and glatiramer acetate in multiple sclerosis.
Annals of Neurology.
73:327-340.
2013
|
|
| 2013
|
Reported mammographic density: film-screen versus digital acquisition..
Radiology.
266:752-758.
2013
|
|
| 2013
|
Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study.
NeuroImage: Clinical.
2:120-131.
2013
|
|
| 2013
|
"Seeing" in NARCOMS: A look at vision-related quality of life in the NARCOMS registry
2013
|
|
| 2013
|
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation
2013
|
|
| 2013
|
A retrospective review of lithium usage in veterans with multiple sclerosis.
Multiple Sclerosis and Related Disorders.
2:327-333.
2013
|
|
| 2013
|
EDSS variability before randomization may limit treatment discovery in primary progressive MS
2013
|
|
| 2013
|
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.
European Journal of Neurology.
20:87-94.
2013
|
|
| 2013
|
Effect of physical comorbidities on risk of depression in Multiple Sclerosis.
International Journal of MS Care.
15:34-43.
2013
|
|
| 2013
|
Indoor carbon monoxide: a case study in England for detection and interventions to reduce population exposure..
Journal of Environmental and Public Health.
2013:735952.
2013
|
|
| 2013
|
National variation of technical factors in computed tomography of the head
2013
|
|
| 2013
|
Preferred sources of health information in persons with multiple sclerosis: Degree of trust and information sought
2013
|
|
| 2013
|
Reply.
Muscle and Nerve.
47:145-146.
2013
|
|
| 2013
|
Substantial burden of dizziness in multiple sclerosis.
Multiple Sclerosis and Related Disorders.
2:21-28.
2013
|
|
| 2013
|
The Multiple Sclerosis Intimacy and Sexuality Questionnaire - Re-validation and development of a 15-item version with a large US sample
2013
|
|
| 2013
|
The magnetic resonance imaging 'rule of five': Predicting the occurrence of relapse
2013
|
|
| 2013
|
Treatment trials in progressive MS - Current challenges and future directions.
Nature Reviews Neurology.
9:496-503.
2013
|
|
| 2012
|
Biomarker positive and negative subjects in the ADNI cohort: Clinical characterization.
Current Alzheimer Research.
9:1135-1141.
2012
|
|
| 2012
|
Cause of death in MS: Long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
BMJ Open.
2.
2012
|
|
| 2012
|
Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival of Dogs With Spontaneous Bone Cancer..
Molecular Therapy.
20:2234-2243.
2012
|
|
| 2012
|
Personalized medicine: The return of the house call?.
Neurology: Clinical Practice.
2:343-351.
2012
|
|
| 2012
|
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.
Contemporary Clinical Trials.
33:1211-1216.
2012
|
|
| 2012
|
No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis.
American Journal of Neuroradiology.
33:1913-1917.
2012
|
|
| 2012
|
Treatment with interferon beta for multiple sclerosis.
Journal of the American Medical Association.
308:1627.
2012
|
|
| 2012
|
Short latency activation of cortex by clinically effective thalamic brain stimulation for tremor.
Movement Disorders.
27:1404-1412.
2012
|
|
| 2012
|
Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States
2012
|
|
| 2012
|
Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
2012
|
|
| 2012
|
Sustainability of the Dissemination of an Occupational Sun Protection Program in a Randomized Trial.
Health Education and Behavior.
39:498-502.
2012
|
|
| 2012
|
Increasing age at disability milestones among MS patients in the MSBase Registry.
Journal of the Neurological Sciences.
318:94-99.
2012
|
|
| 2012
|
Evolution of MS lesions to black holes under DNA vaccine treatment.
Journal of Neurology.
259:1375-1382.
2012
|
|
| 2012
|
Adopting an evidence-based lifestyle physical activity program: Dissemination study design and methods.
Translational Behavioral Medicine.
2:199-208.
2012
|
|
| 2012
|
Psychometric evaluation of the myasthenia gravis composite using rasch analysis.
Muscle and Nerve.
45:820-825.
2012
|
|
| 2012
|
Recommendations for myasthenia gravis clinical trials.
Muscle and Nerve.
45:909-917.
2012
|
|
| 2012
|
Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease.
Movement Disorders.
27:864-873.
2012
|
|
| 2012
|
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects..
Lancet Neurology.
11:467-476.
2012
|
|
| 2012
|
The CombiRx Trial: A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Participants with Relapsing-Remitting Multiple Sclerosis - Clinical Outcomes (PL02.003).
Neurology.
78:pl02.003-pl02.003.
2012
|
|
| 2012
|
High Frequency and Adverse Impact of Vertigo and Dizziness in Multiple Sclerosis (P07.075).
Neurology.
78:p07.075-p07.075.
2012
|
|
| 2012
|
Mortality in Multiple Sclerosis in the United States (MIMS-US): A Retrospective, Cohort Study of Survival and Mortality Trends (P06.195).
Neurology.
78:p06.195-p06.195.
2012
|
|
| 2012
|
Natural History of MS Symptoms: Perceived Disease Impact across Disease Span in Nine Neurologic Domains among Enrollees in North American Research Committee on Multiple Sclerosis (NARCOMS) Registry (P07.073).
Neurology.
78:p07.073-p07.073.
2012
|
|
| 2012
|
A Genetic Model Predicts the Response to Glatiramer Acetate in Two Different Cohorts (P05.129).
Neurology.
78:p05.129-p05.129.
2012
|
|
| 2012
|
Clinical Outcomes and Cause of Death for Interferon Beta-1b Versus Placebo, 21 Years Following Randomization (P04.129).
Neurology.
78:p04.129-p04.129.
2012
|
|
| 2012
|
Psychometric Evaluation of Quality of Life (QoL) and Disease Severity Outcome Measures in Myasthenia Gravis (MG) Using Rasch Analysis (P05.174).
Neurology.
78:p05.174-p05.174.
2012
|
|
| 2012
|
Relationship between Symptom Worsening, Relapse Activity and Disease Progression in Patients with Multiple Sclerosis (P05.094).
Neurology.
78:p05.094-p05.094.
2012
|
|
| 2012
|
A Genetic Model To Predict Response to Glatiramer Acetate Developed from a Genome Wide Association Study (GWAS) (S20.003).
Neurology.
78:s20.003-s20.003.
2012
|
|
| 2012
|
Survival in MS A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
Neurology.
78:1315-1322.
2012
|
|
| 2012
|
The CombiRx Trial: A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Participants with Relapsing Remitting Multiple Sclerosis - MRI Outcomes (S11.002).
Neurology.
78:s11.002-s11.002.
2012
|
|
| 2012
|
A Genetic Model To Predict Response to Glatiramer Acetate Developed from a Genome Wide Association Study (GWAS) (IN3-2.003).
Neurology.
78:in3-2.003-in3-2.003.
2012
|
|
| 2012
|
Amyotrophic Lateral Sclerosis in a Large African American Population, Does It Differ from Caucasians? (P01.098).
Neurology.
78:p01.098-p01.098.
2012
|
|
| 2012
|
Improvements in the Power of Detecting Treatment Effect in a Primary Progressive Multiple Sclerosis (PPMS) Clinical Trial with the Use of Composite Disability Outcome Endpoints (P01.151).
Neurology.
78:p01.151-p01.151.
2012
|
|
| 2012
|
The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics..
Multiple Sclerosis and Related Disorders.
1:81-86.
2012
|
|
| 2012
|
Cumulative impact of comorbidity on quality of life in MS.
Acta Neurologica Scandinavica.
125:180-186.
2012
|
|
| 2012
|
Expanding occupational sun safety to an outdoor recreation industry: A translational study of the Go Sun Smart program.
Translational Behavioral Medicine.
2:10-18.
2012
|
|
| 2012
|
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes..
Diabetes reviews (Alexandria, Va.).
35:574-580.
2012
|
|
| 2012
|
Implementing clinical trials on an international platform: Challenges and perspectives.
Journal of the Neurological Sciences.
313:1-6.
2012
|
|
| 2012
|
Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models..
NeuroImage.
59:2155-2166.
2012
|
|
| 2012
|
Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data..
NeuroImage.
59:2217-2230.
2012
|
|
| 2012
|
Response to the Letter 'Efficiency loss due to varying cluster sizes in cluster randomized trials and how to compensate for it: Comment on You et al. (2011)' by van Breukelen and Candel.
Clinical Trials.
9:126-127.
2012
|
|
| 2012
|
Biomarker development for myasthenia gravis.
Annals of the New York Academy of Sciences.
1275:101-106.
2012
|
|
| 2012
|
Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areas.
Journal of the American Academy of Dermatology.
66:63-70.
2012
|
|
| 2012
|
Enhancing industry-based dissemination of an occupational sun protection program with theory-based strategies employing personal contact.
American Journal of Health Promotion.
26:356-365.
2012
|
|
| 2012
|
Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer.
Molecular Therapy.
20:2234-2243.
2012
|
|
| 2012
|
Statistical cures and other fallacies
2012
|
|
| 2012
|
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics.
Multiple Sclerosis and Related Disorders.
1:81-86.
2012
|
|
| 2012
|
Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease.
Parkinsonism and Related Disorders.
18:63-68.
2012
|
|
| 2011
|
Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis.
Neurology.
77:2089-2096.
2011
|
|
| 2011
|
Re: Practice parameters in myasthenia gravis.
Muscle and Nerve.
44:1001.
2011
|
|
| 2011
|
Real-time quantitative polymerase chain reaction for enumeration of Streptococcus mutans from oral samples.
European Journal of Oral Sciences.
119:447-454.
2011
|
|
| 2011
|
Reply from the authors.
Neurology.
77.
2011
|
|
| 2011
|
To the editor.
Neurology.
77.
2011
|
|
| 2011
|
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS..
Neurology.
77:1551-1560.
2011
|
|
| 2011
|
Randomized trial of oral teriflunomide for relapsing multiple sclerosis..
New England Journal of Medicine.
365:1293-1303.
2011
|
|
| 2011
|
Inhaled nitric oxide in preterm infants: An individual-patient data meta-analysis of randomized trials.
Pediatrics.
128:729-739.
2011
|
|
| 2011
|
Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PD.
Brain and Behavior.
1:12-18.
2011
|
|
| 2011
|
Erratum: Estimating power with effect size versus slope differences: Both means and variance matter (Alzheimer's and Dementia (2011) 7 (247-249)).
Alzheimer's and Dementia.
7:556.
2011
|
|
| 2011
|
Motivating public school districts to adopt sun protection policies: A randomized controlled trial.
American Journal of Preventive Medicine.
41:309-316.
2011
|
|
| 2011
|
Association between comorbidity and clinical characteristics of MS.
Acta Neurologica Scandinavica.
124:135-141.
2011
|
|
| 2011
|
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS.
Neurology.
77:138-144.
2011
|
|
| 2011
|
A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma.
Journal of Veterinary Internal Medicine.
25:890-896.
2011
|
|
| 2011
|
Got milk?.
Annals of Neurology.
70:3-4.
2011
|
|
| 2011
|
O4‐01‐03: Amnestic MCI/ prodromal Alzheimer's disease with more severe memory deficit is indistinguishable from diagnosed Alzheimer disease: Implications for the validity of clinical trials and biomarkers.
Alzheimer's and Dementia.
7:s681-s682.
2011
|
|
| 2011
|
A research model for investigating the effects of artificial food colorings on children with ADHD.
Pediatrics.
127.
2011
|
|
| 2011
|
Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: Evidence from a cross-sectional analysis.
Neuroepidemiology.
36:183-191.
2011
|
|
| 2011
|
Bayesian sample size determination under hypothesis tests.
Contemporary Clinical Trials.
32:393-398.
2011
|
|
| 2011
|
Factors That Predict Adoption and Implementation of an Evidence-based Physical Activity Program.
Medicine and Science in Sports and Exercise.
43:694.
2011
|
|
| 2011
|
Practice parameters and focusing research: Plasma exchange for myasthenia gravis.
Muscle and Nerve.
43:625-626.
2011
|
|
| 2011
|
The association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patients..
Pain Medicine.
12:697-705.
2011
|
|
| 2011
|
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution.
Neurology.
76:1222-1228.
2011
|
|
| 2011
|
Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.
Neuroepidemiology.
36:85-90.
2011
|
|
| 2011
|
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.
2011
|
|
| 2011
|
Continued benefits of a technical assistance web site to local tobacco control coalitions during a state budget shortfall.
Journal of Public Health Management and Practice.
17.
2011
|
|
| 2011
|
Estimating power with effect size versus slop differences: Both means and variance matter.
Alzheimer's and Dementia.
7:247-249.
2011
|
|
| 2011
|
Estimating the density of Antarctic krill (Euphausia superba) from multi-beam echo-sounder observations using distance sampling methods
2011
|
|
| 2011
|
Genetic diversity of plaque mutans streptococci with rep-PCR
2011
|
|
| 2011
|
Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients.
PLoS One.
6.
2011
|
|
| 2011
|
Relative efficiency and sample size for cluster randomized trials with variable cluster sizes.
Clinical Trials.
8:27-36.
2011
|
|
| 2011
|
Risk of serious injury for young baseball pitchers: A 10-year prospective study.
American Journal of Sports Medicine.
39:253-257.
2011
|
|
| 2011
|
Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation.
Pediatric Critical Care Medicine.
12.
2011
|
|
| 2011
|
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis
2011
|
|
| 2011
|
Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach.
Bone.
49:356-367.
2011
|
|
| 2011
|
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis
2011
|
|
| 2011
|
Supporting tobacco control: stimulating local newspaper coverage with a technical assistance website for local coalitions..
Health Promotion Practice.
12.
2011
|
|
| 2011
|
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium
2011
|
|
| 2010
|
Assessing changes in relapse rates in multiple sclerosis
2010
|
|
| 2010
|
Comparative analysis of therapeutic options used for myasthenia gravis.
Annals of Neurology.
68:797-805.
2010
|
|
| 2010
|
Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia..
Pediatrics.
126:e1545-e1552.
2010
|
|
| 2010
|
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma.
BMC Cancer.
10.
2010
|
|
| 2010
|
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis eight-year follow-up.
JAMA Neurology.
67:1329-1335.
2010
|
|
| 2010
|
Environmental cues to UV radiation and personal sun protection in outdoor winter recreation.
JAMA Dermatology.
146:1241-1247.
2010
|
|
| 2010
|
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative..
JAMA Neurology.
67:1370-1378.
2010
|
|
| 2010
|
Composite MRI scores improve correlation with EDSS in multiple sclerosis
2010
|
|
| 2010
|
Poster 230: Hand Function, Mobility, and Employment Status in the NARCOMS Registry
2010
|
|
| 2010
|
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.
Alzheimer's and Dementia.
6:367-377.
2010
|
|
| 2010
|
Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity
2010
|
|
| 2010
|
Temporal characteristics of cold pain perception.
Neuroscience Letters.
480:12-15.
2010
|
|
| 2010
|
O2‐02‐08: Requiring a CSF amyloid‐β42 biomarker for a prodromal AD research diagnosis does not result in better clinical trials: Simulations from the ADNI database.
Alzheimer's and Dementia.
6:s100-s100.
2010
|
|
| 2010
|
Stenting versus endarterectomy for treatment of carotid-artery stenosis.
New England Journal of Medicine.
363:11-23.
2010
|
|
| 2010
|
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.
Annals of Neurology.
67:749-760.
2010
|
|
| 2010
|
Reply from the authors.
Neurology.
74:1554-1555.
2010
|
|
| 2010
|
Variability of two plaque sampling methods in quantitation of streptococcus mutans.
Caries Research.
44:160-164.
2010
|
|
| 2010
|
Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors.
Journal of Clinical Epidemiology.
63:441-451.
2010
|
|
| 2010
|
Inhaled Nitric Oxide in preterm infants: A systematic review and individual patient data meta-analysis.
BMC Pediatrics.
10.
2010
|
|
| 2010
|
Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Longitudinal, Magnetic Resonance Imaging, Blinded Pilot Study.
Journal of Vascular Surgery.
51:794.
2010
|
|
| 2010
|
292 CONSTRAINT-INDUCED MOVEMENT THERAPY FOR IMPAIRED GAIT IN PROGRESSIVE MS: 1-YEAR FOLLOW-UP.
Parkinsonism and Related Disorders.
16:s83.
2010
|
|
| 2010
|
Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS.
Current Medical Research and Opinion.
26:493-500.
2010
|
|
| 2010
|
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Therapeutic Advances in Neurological Disorders.
3:15-28.
2010
|
|
| 2010
|
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.
Annals of Neurology.
68:409-411.
2010
|
|
| 2010
|
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint
2010
|
|
| 2010
|
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis
2010
|
|
| 2010
|
Sample size in obesity trials: Patient perspective versus current practice.
Medical Decision Making.
30:68-75.
2010
|
|
| 2010
|
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.
Neurology.
74:1041-1047.
2010
|
|
| 2009
|
Erratum to "The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial" [J. Neuroimmunol. 201-202(2008)80-84] (DOI:10.1016/j.jneuroim.2008.05.031).
Journal of Neuroimmunology.
217:103.
2009
|
|
| 2009
|
Evidence of treatment benefit: Is seeing believing or obfuscation by statistics?
2009
|
|
| 2009
|
Weight changes associated with unilateral STN DBS and advanced PD.
Parkinsonism and Related Disorders.
15:709-711.
2009
|
|
| 2009
|
Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea..
Pain.
146:91-98.
2009
|
|
| 2009
|
Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year.
Pediatrics.
124:1333-1343.
2009
|
|
| 2009
|
Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial.
Arthritis and Rheumatism.
60:3207-3216.
2009
|
|
| 2009
|
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
JAMA Neurology.
66:1366-1372.
2009
|
|
| 2009
|
A bayesian method of estimating kappa coefficient with application to a rheumatoid arthritis study
2009
|
|
| 2009
|
FP39-WE-01 Long-term follow-up 20 years after the pivotal interferon beta-1b multiple sclerosis trial.
Journal of the Neurological Sciences.
285:s118-s119.
2009
|
|
| 2009
|
Vision related quality of life in multiple sclerosis: Correlation with new measures of low and high contrast letter acuity.
Journal of Neurology, Neurosurgery and Psychiatry.
80:767-772.
2009
|
|
| 2009
|
Testing a theory-based health communication program: A replication of go sun smart in outdoor winter recreation
2009
|
|
| 2009
|
Variability of interpretive accuracy among diagnostic mammography facilities
2009
|
|
| 2009
|
Measuring up rates for adverse health behaviors in multiple sclerosis: The need for action
2009
|
|
| 2009
|
Proof of concept studies for tissue-protective agents in multiple sclerosis
2009
|
|
| 2009
|
Multibeam echosounder observations reveal interactions between Antarctic krill and air-breathing predators
2009
|
|
| 2009
|
Retinal architecture predicts pupillary reflex metrics in MS
2009
|
|
| 2009
|
Factors that influence adherence with disease-modifying therapy in MS.
Journal of Neurology.
256:568-576.
2009
|
|
| 2009
|
Influence of genetic background on tumor karyotypes: Evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma
2009
|
|
| 2009
|
Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress.
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis.
674:93-100.
2009
|
|
| 2009
|
The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and undertreated
2009
|
|
| 2009
|
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach.
Annals of Neurology.
65:268-275.
2009
|
|
| 2009
|
MHC-dependent desensitization of intrinsic anti-self reactivity
2009
|
|
| 2009
|
Predictors of radiologists' perceived risk of malpractice lawsuits in breast imaging.
American Journal of Roentgenology.
192:327-333.
2009
|
|
| 2009
|
Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts data.
Computational Statistics and Data Analysis.
53:820-833.
2009
|
|
| 2009
|
Comorbidity delays diagnosis and increases disability at diagnosis in MS.
Neurology.
72:117-124.
2009
|
|
| 2009
|
High frequency of adverse health behaviors in multiple sclerosis
2009
|
|
| 2009
|
A cross-sectional study of bone health in multiple sclerosis.
Neurology.
73:1394-1398.
2009
|
|
| 2009
|
Differences in Bladder Care for Veterans with Multiple Sclerosis by Treatment Location.
International Journal of MS Care.
11:91-97.
2009
|
|
| 2009
|
Editorial: Relapses in multiple sclerosis: Important or not?.
Neurology.
73:1612-1613.
2009
|
|
| 2009
|
Effect of Physical Comorbidities on Risk of Depression in Multiple Sclerosis.
International Journal of MS Care.
11:161-165.
2009
|
|
| 2008
|
Optical coherence tomography: A window into the mechanisms of multiple sclerosis.
Nature Reviews Neurology.
4:664-675.
2008
|
|
| 2008
|
Comorbidity, socioeconomic status and multiple sclerosis
2008
|
|
| 2008
|
Construction of an efficient evaluative instrument for myasthenia gravis: The MG composite.
Muscle and Nerve.
38:1553-1562.
2008
|
|
| 2008
|
Smoking status over two years in patients with multiple sclerosis.
Neuroepidemiology.
32:72-79.
2008
|
|
| 2008
|
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis: Reply.
Neurology.
71:1747-1748.
2008
|
|
| 2008
|
Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings
2008
|
|
| 2008
|
Effects of program exposure and engagement with tailored prevention communication on sun protection by young adolescents
2008
|
|
| 2008
|
Go Sun Smart.
Communication Education.
57:423-433.
2008
|
|
| 2008
|
Testing the long-term effects of the Go Sun Smart worksite health communication campaign: A group-randomized experimental study.
Journal of Communication.
58:447-471.
2008
|
|
| 2008
|
The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial.
Journal of Neuroimmunology.
201-202:80-84.
2008
|
|
| 2008
|
Bayesian interim analysis in clinical trials.
Contemporary Clinical Trials.
29:751-755.
2008
|
|
| 2008
|
Novel design for clinical trials in multiple sclerosis: Another excursion to Sirenum scopuli?.
Clinical Practice.
5:613-622.
2008
|
|
| 2008
|
Reproducibility of optical coherence tomography in multiple sclerosis.
JAMA Neurology.
65:1218-1222.
2008
|
|
| 2008
|
Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis.
Muscle and Nerve.
38:957-963.
2008
|
|
| 2008
|
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses
2008
|
|
| 2008
|
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
JAMA Neurology.
65:924-928.
2008
|
|
| 2008
|
Increasing Sun Protection in Winter Outdoor Recreation. A Theory-Based Health Communication Program.
American Journal of Preventive Medicine.
34:502-509.
2008
|
|
| 2008
|
Mammography facility characteristics associated with interpretive accuracy of screening mammography
2008
|
|
| 2008
|
Hyperglycemia and adverse pregnancy outcomes.
New England Journal of Medicine.
358:1991-2002.
2008
|
|
| 2008
|
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
2008
|
|
| 2008
|
Randomized trial evaluating computer-based sun safety education for children in elementary school.
Journal of Cancer Education.
23:74-79.
2008
|
|
| 2008
|
Randomized trial on the 5 a day, the Rio Grande way website, a web-based program to improve fruit and vegetable consumption in rural communities
2008
|
|
| 2008
|
Randomized trials on consider this, a tailored, internet-delivered smoking prevention program for adolescents.
Health Education and Behavior.
35:260-281.
2008
|
|
| 2008
|
Corticospinal tract abnormalities are associated with weakness in multiple sclerosis.
American Journal of Neuroradiology.
29:333-339.
2008
|
|
| 2008
|
Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessment.
Neurology.
70:1134-1140.
2008
|
|
| 2008
|
Responsiveness and predictive values in PPMS: An uncertain message.
Neurology.
70:1061-1062.
2008
|
|
| 2008
|
Rules of evidence for clinical trials: The science of finding the truth?.
Annals of the New York Academy of Sciences.
1132:233-237.
2008
|
|
| 2008
|
Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.
Annals of the New York Academy of Sciences.
1132:344-347.
2008
|
|
| 2008
|
Validation of NARCOMS Depression Scale.
International Journal of MS Care.
10:81-84.
2008
|
|
| 2007
|
Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Veterinary Pathology.
44:467-478.
2007
|
|
| 2007
|
Validation of the NARCOMS registry: Diagnosis
2007
|
|
| 2007
|
Disparities in the management of multiple sclerosis-related bladder symptoms.
Neurology.
68:1971-1978.
2007
|
|
| 2007
|
Testing the risk compensation hypothesis for safety helmets in alpine skiing and snowboarding.
Injury Prevention.
13:173-177.
2007
|
|
| 2007
|
Randomized trial on sun safety education at ski and snowboard schools in western North America.
Pediatric Dermatology.
24:222-229.
2007
|
|
| 2007
|
Influence of computer-aided detection on performance of screening mammography.
New England Journal of Medicine.
356:1399-1409.
2007
|
|
| 2007
|
Interferon-β for multiple sclerosis: Long-term benefits?.
Annals of Neurology.
61:283-285.
2007
|
|
| 2007
|
Effect of emailed messages on return use of a nutrition education website and subsequent changes in dietary behavior
2007
|
|
| 2007
|
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial.
Annals of Neurology.
61:14-24.
2007
|
|
| 2007
|
Optical coherence tomography and disease subtype in multiple sclerosis.
Neurology.
69:2085-2092.
2007
|
|
| 2007
|
Persistent pain and uncomfortable sensations in persons with multiple sclerosis.
Pain.
127:35-41.
2007
|
|
| 2007
|
Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma [7].
Leukemia.
21:184-187.
2007
|
|
| 2007
|
Relation of vision to global and regional brain MRI in multiple sclerosis.
Neurology.
69:2128-2135.
2007
|
|
| 2007
|
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
Neurology.
69:1603-1609.
2007
|
|
| 2006
|
Mediation of a middle school skin cancer prevention program.
Health Psychology.
25:616-625.
2006
|
|
| 2006
|
Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure.
New England Journal of Medicine.
355:354-364.
2006
|
|
| 2006
|
Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation.
Experimental Hematology.
34:870-878.
2006
|
|
| 2006
|
Reality check: Perceived versus actual performance of community mammographers.
American Journal of Roentgenology.
187:42-46.
2006
|
|
| 2006
|
Naturally occurring translational models for development of cancer gene therapy.
Gene therapy & molecular biology.
10:31-40.
2006
|
|
| 2006
|
Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: Results from the IMPACT study
2006
|
|
| 2006
|
Does multiple sclerosis-associated disability differ between races?.
Neurology.
66:1235-1240.
2006
|
|
| 2006
|
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
JAMA Neurology.
63:614-619.
2006
|
|
| 2006
|
Futility studies: Spending a little to save a lot.
Neurology.
66:626-627.
2006
|
|
| 2006
|
Impact of customized videotape education on quality of life in patients with chronic obstructive pulmonary disease.
Journal of Cardiopulmonary Rehabilitation and Prevention.
26:112-117.
2006
|
|
| 2006
|
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis [3].
Neurology.
66:954.
2006
|
|
| 2006
|
Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An update.
Obesity Reviews.
7:79-88.
2006
|
|
| 2006
|
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
2006
|
|
| 2006
|
Effects of the Sunny Days, Healthy Ways curriculum on students in grades 6 to 8.
American Journal of Preventive Medicine.
30:13-22.
2006
|
|
| 2006
|
Infectious causes of multiple sclerosis.
Lancet Neurology.
5:887-894.
2006
|
|
| 2005
|
Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients
2005
|
|
| 2005
|
Changes in the ascertainment of multiple sclerosis.
Neurology.
65:1066-1070.
2005
|
|
| 2005
|
MRI as a marker for disease heterogeneity in multiple sclerosis.
Neurology.
65:1071-1076.
2005
|
|
| 2005
|
Validation of the NARCOMS Registry: Fatique assessment
2005
|
|
| 2005
|
Can We Improve Resting Energy Expenditure (REE) Predictions Using a Pooled Data Set and New Formulas?.
Journal of the Academy of Nutrition and Dietetics.
105:17.
2005
|
|
| 2005
|
Randomized trial testing a worksite sun protection program in an outdoor recreation industry.
Health Education and Behavior.
32:514-535.
2005
|
|
| 2005
|
Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk.
Cancer Research.
65:5654-5661.
2005
|
|
| 2005
|
Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography.
Radiology.
236:37-46.
2005
|
|
| 2005
|
Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens.
Stroke.
36:1622-1623.
2005
|
|
| 2005
|
The Goldman Consensus statement on depression in multiple sclerosis
2005
|
|
| 2005
|
Validation of the NARCOMS registry: Pain assessment
2005
|
|
| 2005
|
Current realities of delivering mammography services in the community: Do challenges with staffing and scheduling exist?.
Radiology.
235:391-395.
2005
|
|
| 2005
|
Mammographers' perception of women's breast cancer risk.
Medical Decision Making.
25:283-289.
2005
|
|
| 2005
|
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
Neurology.
64:992-995.
2005
|
|
| 2005
|
Physician predictors of mammographic accuracy
2005
|
|
| 2005
|
Assessing accuracy of mammography in the presence of verification bias and intrareader correlation.
Biometrics.
61:259-268.
2005
|
|
| 2005
|
Association between mammography timing and measures of screening performance in the United States.
Radiology.
234:363-373.
2005
|
|
| 2005
|
Community-based mammography practice: Services, charges, and interpretation methods.
American Journal of Roentgenology.
184:433-438.
2005
|
|
| 2005
|
Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?.
International Journal of Obesity.
29:443-446.
2005
|
|
| 2005
|
Longitudinal Assessment of Multiple Sclerosis Patients and Reimbursement Issues.
International Journal of MS Care.
7:129-131.
2005
|
|
| 2005
|
Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care.
Diabetes reviews (Alexandria, Va.).
28:33-39.
2005
|
|
| 2004
|
Accuracy of screening mammography interpretation by characteristics of radiologists
2004
|
|
| 2004
|
A practical randomized trial to improve diabetes care.
Journal of General Internal Medicine.
19:1167-1174.
2004
|
|
| 2004
|
Prevalence and diffusion of helmet use at ski areas in Western North America in 2001-02.
Injury Prevention.
10:358-362.
2004
|
|
| 2004
|
CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease.
Journal of the Neurological Sciences.
225:79-83.
2004
|
|
| 2004
|
Clinical characteristics of progressive relapsing multiple sclerosis
2004
|
|
| 2004
|
Effect of breast augmentation on the accuracy of mammography and cancer characteristics.
Women's Oncology Review.
4:163-164.
2004
|
|
| 2004
|
The MS Co-Operative Research (MS-CORE) group: An alternate approach to fostering multicenter studies [1]
2004
|
|
| 2004
|
The association between obesity and screening mammography accuracy.
JAMA Internal Medicine.
164:1140-1147.
2004
|
|
| 2004
|
Radiologist uncertainty and the interpretation of screening.
Medical Decision Making.
24:255-264.
2004
|
|
| 2004
|
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite
2004
|
|
| 2004
|
Effect of Breast Augmentation on the Accuracy of Mammography and Cancer Characteristics.
Journal of the American Medical Association.
291:442-450.
2004
|
|
| 2004
|
The Practical Use of Charts to Estimate Resting Energy Expenditure in Adults.
Topics in Clinical Nutrition.
19:51-56.
2004
|
|
| 2003
|
Effect of relapses on development of residual deficit in multiple sclerosis.
Neurology.
61:1528-1532.
2003
|
|
| 2003
|
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Journal of Clinical Oncology.
21:4314-4321.
2003
|
|
| 2003
|
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.
Neurology.
61:1367-1373.
2003
|
|
| 2003
|
Enhancing antimelanoma immune responses through apoptosis.
Cancer Gene Therapy.
10:726-736.
2003
|
|
| 2003
|
A randomized controlled study of the acute and chronic effects of cooling therapy for MS..
Neurology.
60:1955-1960.
2003
|
|
| 2003
|
Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosis
2003
|
|
| 2003
|
Optimization of technique factors for a silicon diode array full-field digital mammography system and comparison to screen-film mammography with matched average glandular dose.
Medical Physics.
30:334-340.
2003
|
|
| 2003
|
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
ACP journal club.
138:168-175.
2003
|
|
| 2003
|
Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis
2003
|
|
| 2003
|
The prevalence and predictors of helmet use by skiers and snowboarders at ski areas in western north america in 2001.
Journal of Trauma and Acute Care Surgery.
55:939-945.
2003
|
|
| 2002
|
Eight-year follow-up study of brain atrophy in patients with MS.
Neurology.
59:1412-1420.
2002
|
|
| 2002
|
Detection of ductal carcinoma in situ in women undergoing screening mammography
2002
|
|
| 2002
|
Benefit of interferon β-1a on MSFC progression in secondary progressive MS.
Neurology.
59:679-687.
2002
|
|
| 2002
|
Performance of diagnostic mammography for women with signs or symptoms of breast cancer
2002
|
|
| 2002
|
Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer.
American Journal of Roentgenology.
179:671-677.
2002
|
|
| 2002
|
Mammography screening and differences in stage of disease by race/ethnicity.
American Journal of Public Health.
92:1144-1150.
2002
|
|
| 2002
|
Performance comparison of full-field digital mammography to screen-film mammography in clinical practice.
Medical Physics.
29:830-834.
2002
|
|
| 2002
|
The Multiple Sclerosis Functional Composite: A new clinical outcome measure for multiple sclerosis trials
2002
|
|
| 2001
|
Modelling new enhancing MRI lesion counts in multiple sclerosis
2001
|
|
| 2001
|
Competing demands in the office visit: What influences mammography recommendations?
2001
|
|
| 2001
|
Use of the multiple sclerosis functional composite to predict disability in relapsing MS.
Neurology.
56:1324-1330.
2001
|
|
| 2001
|
Hypothermia as a risk factor for pediatric cardiothoracic surgical site infection
2001
|
|
| 2001
|
Comparison of full-field digital mammography with screen-film mammography for cancer detection: Results of 4,945 paired examinations.
Radiology.
218:873-880.
2001
|
|
| 2001
|
Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic setting.
American Journal of Roentgenology.
176:1241-1248.
2001
|
|
| 2001
|
The effect of degree of refractive error on hydrogel contact lens-induced complications and patient self-management behaviors.
Optometry and Vision Science.
78:652-656.
2001
|
|
| 2001
|
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
JAMA Neurology.
58:961-967.
2001
|
|
| 2000
|
Performance of screening mammography among women with and without a first-degree relative with breast cancer.
ACP journal club.
133:855-863.
2000
|
|
| 2000
|
Clinical significance of the multiple sclerosis functional composite: Relationship to patient-reported quality of life.
JAMA Neurology.
57:1319-1324.
2000
|
|
| 2000
|
Intrarater and interrater reliability of the MS functional composite outcome measure.
Neurology.
54:802-806.
2000
|
|
| 2000
|
Validity of self-reported colorectal cancer screening behavior.
Cancer Epidemiology, Biomarkers and Prevention.
9:229-232.
2000
|
|
| 2000
|
New low-contrast vision charts: Reliability and test characteristics in patients with multiple sclerosis
2000
|
|
| 2000
|
Relationship between brain atrophy and disability: An 8-year follow-up study of multiple sclerosis patients
2000
|
|
| 2000
|
Self-reported visual dysfunction in multiple sclerosis: Results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25)
2000
|
|
| 1999
|
Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial
1999
|
|
| 1999
|
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.
1999
|
|
| 1999
|
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
1999
|
|
| 1999
|
The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment
1999
|
|
| 1999
|
A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites
1999
|
|
| 1999
|
Practice patterns of family physicians in practice-based research networks: a report from ASPN. Ambulatory Sentinel Pratice Network.
1999
|
|
| 1999
|
Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: The design of two randomized trials.
Preventive Medicine.
28:229-242.
1999
|
|
| 1998
|
The prospective relationships between smoking and weight in a young, biracial cohort: The Coronary Artery Risk Development in Young Adults study.
Journal of Consulting and Clinical Psychology.
66:987-993.
1998
|
|
| 1998
|
Improvement in mammography quality control: 1987-1995.
Radiology.
207:663-668.
1998
|
|
| 1998
|
Pathogenetic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat.
Carcinogenesis.
19:223-227.
1998
|
|
| 1998
|
The cancer information service research consortium: An emerging laboratory for cancer control research.
Preventive Medicine.
27.
1998
|
|
| 1998
|
The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease [1] (multiple letters).
Obstetrics and Gynecology.
91:156-157.
1998
|
|
| 1997
|
The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease.
Obstetrics and Gynecology.
90:347-352.
1997
|
|
| 1997
|
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn..
Journal of Pediatrics.
131:55-62.
1997
|
|
| 1997
|
THE EFFECTS OF TECHNIQUE VARIATIONS ON KNEE BIOMECHANICS DURING THE SQUAT AND LEG PRESS 887.
Medicine and Science in Sports and Exercise.
29:156.
1997
|
|
| 1997
|
Impact of Maternal Group B Streptococcal Screening on Pediatric Management in Full-Term Newborns.
Obstetrical and Gynecological Survey.
52:168-169..
1997
|
|
| 1997
|
Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS).
Journal of the American College of Cardiology.
29:358-364.
1997
|
|
| 1997
|
A classification system to evaluate weight maintainers, gainers, and losers.
Journal of the Academy of Nutrition and Dietetics.
97:481-488.
1997
|
|
| 1997
|
Evaluating the value of low-vision services.
1997
|
|
| 1997
|
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.
Journal of Pediatrics.
131:55-62.
1997
|
|
| 1997
|
Recommendations from the national multiple sclerosis society clinical outcomes assessment task force.
Annals of Neurology.
42:379-382.
1997
|
|
| 1996
|
RANDOMIZED, MULTICENTER TRIAL OF INHALED NITRIC OXIDE AND HIGH FREQUENCY OSCILLATORY VENTILATION IN SEVERE PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN). • 1315.
Pediatric Research.
39:222-222.
1996
|
|
| 1996
|
Clinical outcomes assessment in multiple sclerosis.
Annals of Neurology.
40:469-479.
1996
|
|
| 1996
|
Clinical outcomes assessment in multiple sclerosis: Part II
1996
|
|
| 1996
|
Impact of maternal group B streptococcal screening on pediatric management in full-term newborns.
JAMA Pediatrics.
150:802-808.
1996
|
|
| 1996
|
Methodological issues in weight cycling.
Annals of Behavioral Medicine.
18:280-289.
1996
|
|
| 1996
|
The clinical presentation, prevalence, and risk factors of focal corneal infiltrates in soft contact lens wearers
1996
|
|
| 1995
|
A CASE CONTROL STUDY OF RISK FACTORS IN DEVELOPMENT OF FOCAL CORNEAL INFILTRATES WITH OVERLYING FLUORESCEIN STAINING..
Optometry and Vision Science.
72:90.
1995
|
|
| 1995
|
CLINICAL PRESENTATION AND SYMPTOMATOLOGY OF PATIENTS WITH FOCAL CORNEAL INFILTRATES WITH OVERLYING FLUORESCEIN STAINING.
Optometry and Vision Science.
72:89.
1995
|
|
| 1995
|
ETHNICITY AS A RISK FACTOR FOR CONTACT LENS RELATED BIOMICRO-SCOPIC SIGNS..
Optometry and Vision Science.
72:89.
1995
|
|
| 1995
|
Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.
ACOG Current Journal Review.
8:18-19.
1995
|
|
| 1995
|
The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants..
Journal of Perinatology.
15:185-191.
1995
|
|
| 1995
|
Psychological correlates of weight fluctuation..
International Journal of Eating Disorders.
17:263-275.
1995
|
|
| 1995
|
Optometric Care and Undetected Eye Disease: A Case of Berkson's Bias?.
JAMA Internal Medicine.
155:427-429.
1995
|
|
| 1995
|
Optometric care and undetected eye disease: a case of Berkson's bias?.
Archives of Internal Medicine.
155:427-427.
1995
|
|
| 1995
|
Cervical examination and tocodynamometry at 28 weeks' gestation: prediction of spontaneous preterm birth..
American Journal of Obstetrics and Gynecology.
172:666-671.
1995
|
|
| 1995
|
A new device for collecting cord blood.
Obstetrics and Gynecology.
86:850-852.
1995
|
|
| 1995
|
Cervical examination and tocodynamometry at 28 weeks' gestation: Prediction of spontaneous preterm birth.
American Journal of Obstetrics and Gynecology.
172:666-671.
1995
|
|
| 1995
|
Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis.
Annals of Neurology.
37:5-6.
1995
|
|
| 1995
|
Differences in the detection and enumeration of mutans streptococci due to differences in methods.
Archives of Oral Biology.
40:345-351.
1995
|
|
| 1995
|
Fetal growth in women using low-dose aspirin for the prevention of preeclampsia: Effect of maternal size.
Journal of Maternal-Fetal Medicine.
4:218-224.
1995
|
|
| 1995
|
Impact of patient history on residents' evaluation of child sexual abuse.
Child Abuse and Neglect.
19:943-951.
1995
|
|
| 1995
|
Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality.
Obstetrics and Gynecology.
85:1055-1058.
1995
|
|
| 1995
|
Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.
American Journal of Obstetrics and Gynecology.
173:578-584.
1995
|
|
| 1995
|
Psychological correlates of weight fluctuation.
International Journal of Eating Disorders.
17:263-275.
1995
|
|
| 1995
|
The Effect of Cigarette Smoking on Neonatal Anthropometric Measurements.
Obstetrics and Gynecology.
85:625-630.
1995
|
|
| 1995
|
The relationship between maternal and neonatal anthropometric measurements in term newborns.
Obstetrics and Gynecology.
85:192-196.
1995
|
|
| 1995
|
The self-management behaviors of soft contact lens wearers: The effect of lens modality.
International contact lens clinic (New York, N.Y.).
22:117-123.
1995
|
|
| 1995
|
Who Are the Weight Maintainors?.
Obesity.
3:249s-259s.
1995
|
|
| 1994
|
A study of the reliability and comparative validity of the cardia dietary history.
1994
|
|
| 1994
|
CLINICAL PRESENTATION, PREVALENCE AND RISK FACTORS OF FOCAL INFILTRATES IN GENERAL EYE CARE PRACTICES.
Optometry and Vision Science.
71:76.
1994
|
|
| 1994
|
LENS CARE SYSTEMS, COMPLIANCE, AND CONTACT LENS-RELATED SIGNS AND SYMPTOMS.
Optometry and Vision Science.
71:98.
1994
|
|
| 1994
|
SELF-MANAGEMENT AMONG CONTACT LENS WEARERS: DIFFERENCES BETWEEN DISPOSABLE AND CONVENTIONAL LENS WEARERS.
Optometry and Vision Science.
71:158.
1994
|
|
| 1994
|
THE EFFECT OF THE DEGREE OF REFRACTIVE ERROR ON HYDROGEL CONTACT LENS WEAR.
Optometry and Vision Science.
71:77.
1994
|
|
| 1994
|
Bed rest in pregnancy.
Obstetrics and Gynecology.
84:131-136.
1994
|
|
| 1994
|
Characteristics of severe hypoglycemia in the patient with insulin-dependent diabetes.
Southern Medical Journal.
87:616-620.
1994
|
|
| 1994
|
Data discrepancies and audit effects in the umbilical artery catheter trial.
Therapeutic Innovation & Regulatory Science.
28:891-897.
1994
|
|
| 1994
|
Diagnoses, symptoms, and attribution of symptoms among black and white inpatients admitted for coronary heart disease.
American Journal of Public Health.
84:951-956.
1994
|
|
| 1994
|
Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns.
Journal of Clinical Oncology.
12:1783-1788.
1994
|
|
| 1994
|
Low‐dose aspirin therapy to prevent preeclampsia.
International Journal of Gynecology and Obstetrics.
44:97-97.
1994
|
|
| 1994
|
Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis.
Obstetrics and Gynecology.
83:483-494.
1994
|
|
| 1993
|
Rose Questionnaire responses among black and white inpatients admitted for coronary heart disease: findings from the Birmingham-BHS Project.
1993
|
|
| 1993
|
Elevated levels of midtrimester maternal serum‐fetoprotein are associated with preterm delivery but not with fetal growth retardation.
International Journal of Gynecology and Obstetrics.
41:219-219.
1993
|
|
| 1993
|
Fetal biparietal diameter, head circumference, abdominal circumference and femur length: A comparison by race and sex
1993
|
|
| 1993
|
Promoting physical activity in low-income African-American communities: the PARR project.
1993
|
|
| 1993
|
Initial Acquisition of Mutans Streptococci by Infants: Evidence for a Discrete Window of Infectivity
1993
|
|
| 1993
|
Low-dose aspirin therapy to prevent preeclampsia.
American Journal of Obstetrics and Gynecology.
168:1083-1093.
1993
|
|
| 1993
|
Maternal risk factors and their influence on fetal anthropometric measurements.
American Journal of Obstetrics and Gynecology.
168:1197-1205.
1993
|
|
| 1993
|
Physical activity of public housing residents in Birmingham, Alabama.
American Journal of Public Health.
83:1016-1020.
1993
|
|
| 1993
|
Radiographic Changes Associated with Tracheal Isolation of Ureaplasma Urealyticum from Neonates.
Clinical Infectious Diseases.
17:S122-S130.
1993
|
|
| 1993
|
The feasibility of long-term treatment of diabetes with continuous subcutaneous insulin infusion.
Diabetes, nutrition & metabolism.
6:57-60.
1993
|
|
| 1993
|
The relationship between maternal hematocrit and pregnancy outcome: black-white differences..
Journal of the National Medical Association.
85:130-134.
1993
|
|
| 1993
|
Transmission of mutans streptococci to infants following short term application of an iodine‐NaF solution to mothers' dentition.
Community Dentistry and Oral Epidemiology.
21:136-142.
1993
|
|
| 1992
|
Serum folate and fetal growth retardation: a matter of compliance?.
Obstetrics and Gynecology.
79:719-722.
1992
|
|
| 1992
|
Blood pressure, growth retardation, and preterm delivery.
International Journal of Technology Assessment in Health Care.
8:82-90.
1992
|
|
| 1992
|
Distributed data analysis in a multicenter study: The CARDIA study.
Contemporary Clinical Trials.
13:80-90.
1992
|
|
| 1992
|
Effect of conventional dental restorative treatment on bacteria in saliva.
Community Dentistry and Oral Epidemiology.
20:138-143.
1992
|
|
| 1992
|
Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
American Journal of Obstetrics and Gynecology.
167:596-601.
1992
|
|
| 1992
|
Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male.
Urology.
40:36-40.
1992
|
|
| 1992
|
Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome.
American Journal of Clinical Nutrition.
56:365-370.
1992
|
|
| 1992
|
Relationship of intraventricular hemorrhage or death with the level of umbilical artery catheter placement: A multicenter randomized clinical trial.
Pediatrics.
90:881-887.
1992
|
|
| 1992
|
Serum folate and fetal growth retardation: A matter of compliance?.
Obstetrics and Gynecology.
79:719-722.
1992
|
|
| 1992
|
Symptom-limited graded treadmill exercise testing in young adults in the CARDIA study.
Medicine and Science in Sports and Exercise.
24:177-183.
1992
|
|
| 1992
|
The influence of previous low birth weight on birth weight, gestational age, and anthropometric measurements in the current pregnancy.
Obstetrics and Gynecology.
79:276-280.
1992
|
|
| 1992
|
The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardation.
Obstetrics and Gynecology.
80:262-267.
1992
|
|
| 1992
|
Usefulness of various maternal skinfold measurements for predicting newborn birth weight.
Journal of the Academy of Nutrition and Dietetics.
92:1393-1394.
1992
|
|
| 1991
|
Black-white differences in newborn anthropometric measurements..
Obstetrics and Gynecology.
78:782-788.
1991
|
|
| 1991
|
Cardiovascular risk factors in young adults. The CARDIA baseline monograph..
Contemporary Clinical Trials.
12:1S-77S.
1991
|
|
| 1991
|
Black-white differences in newborn anthropometric measurements.
Obstetrics and Gynecology.
78:782-788.
1991
|
|
| 1991
|
Cardiovascular risk factors in young adults. The CARDIA baseline monograph.
Contemporary Clinical Trials.
12:1-77.
1991
|
|
| 1991
|
Maternal serum alpha2-macroglobulin and fetal growth retardation.
Obstetrics and Gynecology.
78:594-599.
1991
|
|
| 1991
|
Oral leukoplakia and adolescent smokeless tobacco use.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
72:35-41.
1991
|
|
| 1991
|
Risk factors and the natural history of coronary heart disease in blacks.
Cardiovascular clinics.
21:29-45.
1991
|
|
| 1991
|
The relationship between maternal hematocrit and pregnancy outcome.
Obstetrics and Gynecology.
77:190-194.
1991
|
|
| 1991
|
The relationship between maternal serum zinc levels during pregnancy and birthweight.
Early Human Development.
25:75-85.
1991
|
|
| 1990
|
Intrauterine growth retardation and preterm delivery: Prenatal risk factors in an indigent population.
International Journal of Gynecology and Obstetrics.
33:85-85.
1990
|
|
| 1990
|
Estimating the Mean, Variance, and Confidence Limits from Censored (Limit of Detection), Lognormally-Distributed Exposure Data.
AIHA journal : a journal for the science of occupational and environmental health and safety.
51:416-419.
1990
|
|
| 1990
|
A positive association between maternal serum zinc concentration and birth weight.
American Journal of Clinical Nutrition.
51:678-684.
1990
|
|
| 1990
|
Alcohol intake and blood pressure in young adults: The CARDIA study.
Journal of Clinical Epidemiology.
43:1-13.
1990
|
|
| 1990
|
Cigarette smoking behavior is strongly related to educational status: The cardia study.
Preventive Medicine.
19:158-169.
1990
|
|
| 1990
|
Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population.
American Journal of Obstetrics and Gynecology.
162:213-218.
1990
|
|
| 1990
|
Intrauterine growth retardation is not the same as small for gestational age (I: Reply).
American Journal of Obstetrics and Gynecology.
162:1643.
1990
|
|
| 1990
|
Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults Study.
American Journal of Public Health.
80:1053-1056.
1990
|
|
| 1990
|
Reply.
American Journal of Obstetrics and Gynecology.
162:1643.
1990
|
|
| 1990
|
Smoking, maternal age, fetal growth, and gestational age at delivery.
American Journal of Obstetrics and Gynecology.
162:53-58.
1990
|
|
| 1990
|
The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: Results of a cross-sectional study in patients from the Hypertension Detection and Follow-up Program.
Journal of Human Hypertension.
4:491-500.
1990
|
|
| 1990
|
Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm delivery.
American Journal of Obstetrics and Gynecology.
162:748-754.
1990
|
|
| 1989
|
Efficacy of a premixed semisynthetic human insulin regimen
1989
|
|
| 1989
|
Patient preference between clear and yellow lenses for binocular indirect ophthalmoscopy.
Clinical eye and vision care.
1:163-165.
1989
|
|
| 1989
|
A Randomized, Controlled Trial of Very Early Prophylactic Ligation of the Ductus Arteriosus in Babies Who Weighed 1000 g or Less at Birth.
New England Journal of Medicine.
320:1511-1516.
1989
|
|
| 1989
|
Effects of very low birth weights on fetal and neonatal mortality rates in Alabama.
Public Health Reports.
104:488-492.
1989
|
|
| 1989
|
Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study.
Hypertension.
14:218-226.
1989
|
|
| 1989
|
Fluorescence microscopy of DES‐induced morphologic transformation in unfixed, cultured cells.
Journal Of Oral Pathology and Medicine.
18:451-456.
1989
|
|
| 1989
|
Intrauterine growth retardation: Standards for diagnosis.
American Journal of Obstetrics and Gynecology.
161:271-277.
1989
|
|
| 1989
|
Portable tonometers: a clinical comparison of applanation and indentation devices.
1989
|
|
| 1989
|
Preliminary Results From The Collaborative Alabama And Scandinavian Study Of Successive Small‐For‐Gestational Age Births: Report From a Symposium In Trondheim 9th June 1988.
Acta Obstetricia et Gynecologica Scandinavica.
68:19-25.
1989
|
|
| 1989
|
Prematurity, postdates, and growth retardation: The influence of use of ultrasonography on reported gestational age.
American Journal of Obstetrics and Gynecology.
160:462-470.
1989
|
|
| 1989
|
Sensitivity, specificity and predictive value of saliva thiocyanate among pregnant women.
Addictive Behaviors.
14:447-452.
1989
|
|
| 1988
|
ASSOCIATION OF UREAPLASMA UREALYTICUM INFECTION OF THE LOWER RESPIRATORY TRACT WITH CHRONIC LUNG DISEASE AND DEATH IN VERY-LOW-BIRTH-WEIGHT INFANTS
1988
|
|
| 1988
|
A cost-effectiveness analysis of self-help smoking cessation methods for pregnant women.
Public Health Reports.
103:83-88.
1988
|
|
| 1988
|
Cardia: study design, recruitment, and some characteristics of the examined subjects.
Journal of Clinical Epidemiology.
41:1105-1116.
1988
|
|
| 1988
|
Condylomata acuminata in IDDM..
Diabetes reviews (Alexandria, Va.).
11:295-296.
1988
|
|
| 1988
|
Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery disease.
Therapeutic Innovation & Regulatory Science.
22:425-448.
1988
|
|
| 1988
|
Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery disease.
Therapeutic Innovation & Regulatory Science.
22:425-448.
1988
|
|
| 1988
|
Factors associated with discontinuation of continuous subcutaneous insulin infusion.
American Journal of the Medical Sciences.
295:23-28.
1988
|
|
| 1988
|
Plasmid-containing strains of Streptococcus mutans cluster within family and racial cohorts: Implications for natural transmission.
Infection and Immunity.
56:3216-3220.
1988
|
|
| 1988
|
Relationships of low density lipoprotein cholesterol with age and other factors: A cross-sectional analysis of the CARDIA study.
Annals of clinical research.
20:32-38.
1988
|
|
| 1987
|
A study of the cost of tuberculosis contact investigation related to non-tuberculous Mycobacterial isolation in Jefferson County, Alabama.
Public Health.
101:297-304.
1987
|
|
| 1987
|
Comparison of hypertension prevalence and control in 5,237 rural and urban Alabama residents.
Southern Medical Journal.
80:1220-1223.
1987
|
|
| 1987
|
Fetal deaths in Alabama, 1974-1983: A birth weight-specific analysis.
Obstetrics and Gynecology.
70:831-835.
1987
|
|
| 1987
|
Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) study.
Contemporary Clinical Trials.
8:68-73.
1987
|
|
| 1986
|
Prediction of response to sodium intervention for blood pressure control.
Journal of Hypertension.
4.
1986
|
|
| 1986
|
DDT contamination of a North Alabama aquatic ecosystem.
Environmental Toxicology and Chemistry.
5:725-736.
1986
|
|
| 1985
|
Low birth weight, intrauterine growth retardation, and preterm delivery.
American Journal of Obstetrics and Gynecology.
152:980-984.
1985
|
|
| 1985
|
The Natural History of Smoking Cessation Among Patients Undergoing Coronary Arteriography.
Journal of Cardiopulmonary Rehabilitation and Prevention.
5:332???340.
1985
|
|
| 1985
|
Effective dietary intervention in hypertensives: sodium restriction and weight reduction..
Journal of the Academy of Nutrition and Dietetics.
85:423-430.
1985
|
|
| 1985
|
Dietary therapy slows the return of hypertension after stopping prolonged medication.
Journal of the American Medical Association.
253:657-664.
1985
|
|
| 1985
|
Neonatal mortality in infants born weighing 501 to 1000 grams. The influence of changes in birth weight distribution and birth weight-specific mortality rates on neonatal survival.
American Journal of Obstetrics and Gynecology.
151:608-611.
1985
|
|
| 1985
|
Dietary Therapy Slows the Return of Hypertension After Stopping Prolonged Medication.
Journal of the American Medical Association.
253:657-657.
1985
|
|
| 1985
|
Dietary Therapy Slows the Return of Hypertension After Stopping Prolonged Medication.
Journal of the American Medical Association.
253:657-664.
1985
|
|
| 1985
|
Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function.
Journal of the American College of Cardiology.
5:1036-1045.
1985
|
|
| 1985
|
The Risk of Bladder Calculi in Patients With Spinal Cord Injuries.
JAMA Internal Medicine.
145:428-430.
1985
|
|
| 1985
|
The effectiveness of smoking cessation methods for smokers in public health maternity clinics: A randomized trial.
American Journal of Public Health.
75:1389-1392.
1985
|
|
| 1985
|
The natural history of smoking cessation among patients undergoing coronary arteriography.
Journal of Cardiopulmonary Rehabilitation and Prevention.
5:332-340.
1985
|
|
| 1984
|
Does effective antihypertensive therapy partially "cure" hypertension?.
Transactions of the American Clinical and Climatological Association.
96:111-119.
1984
|
|
| 1984
|
Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH).
Journal of Hypertension.
2:179-181.
1984
|
|
| 1984
|
Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension..
Journal of Hypertension.
2:S179-S181.
1984
|
|
| 1984
|
Return of hypertension after withdrawal of prolonged antihypertensive therapy, effect of weight loss, sodium reduction, and baseline factors..
Proceedings of the Association of American Physicians.
97:190-196.
1984
|
|
| 1984
|
Response from Findley, et al.
American Journal of Public Health.
74:392-392.
1984
|
|
| 1984
|
Association of factor B with ischemic heart disease (IHD)..
Progress in clinical and biological research.
147:479-480.
1984
|
|
| 1984
|
Issues in the natural history and treatment of coronary heart disease in black populations: Surgical treatment.
American Heart Journal.
108:688-694.
1984
|
|
| 1984
|
The risk of renal calculi in spinal cord injury patients.
Investigative urology.
131:857-859.
1984
|
|
| 1983
|
Baseline physical examination characteristics of the hypertensive participants.
Hypertension.
5.
1983
|
|
| 1983
|
Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants..
Hypertension.
5.
1983
|
|
| 1983
|
An assessment of the environmental protection agency's asbestos hazard evaluation algorithm.
American Journal of Public Health.
73:1179-1181.
1983
|
|
| 1983
|
Baseline medical history characteristics of the hypertensive participants.
Hypertension.
5:51-91.
1983
|
|
| 1983
|
Baseline physical examination characteristics of the hypertensive participants.
Hypertension.
5:92-132.
1983
|
|
| 1983
|
Quasi-experimental designs for evaluating cancer control programs in rural settings..
Progress in clinical and biological research.
120:55-70.
1983
|
|
| 1983
|
Training and certification of blood pressure observers.
Hypertension.
5:610-614.
1983
|
|
| 1982
|
Epidemiologic study of candidates for coronary artery bypass surgery..
Circulation.
66:III6-II15.
1982
|
|
| 1982
|
Selenium in reducing waters..
Science.
217:829-831.
1982
|
|
| 1982
|
Correlates of attendance and compliance in the hypertension detection and follow-up program.
Contemporary Clinical Trials.
3:13-27.
1982
|
|
| 1982
|
Epidemiologic study of candidates for coronary artery bypass surgery.
Circulation.
66.
1982
|
|
| 1982
|
Methodological issues in using time series designs and analysis: evaluating the behavioral impact of health communication programs..
Progress in clinical and biological research.
83:517-535.
1982
|
|
| 1982
|
Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the hypertension detection and follow-up program cooperative group.
Preventive Medicine.
11:487-499.
1982
|
|
| 1982
|
Validation of a risk function to predict mortality in a VA population with coronary artery disease.
Contemporary Clinical Trials.
3:47-60.
1982
|
|
| 1981
|
Urinary Glycosaminoglycan Excretion as a Biochemical Marker in Patients with Bladder Carcinoma.
Cancer Research.
41:3868-3873.
1981
|
|
| 1981
|
Cohort analysis of secular change in mortality in patients with cad undergoing surgical intervention.
American Journal of Cardiology.
47:487.
1981
|
|
| 1981
|
Increasing utilization of a rural cervical cancer detection program.
American Journal of Public Health.
71:641-643.
1981
|
|
| 1980
|
A two-compartment regression model applied to compliance in a hypertension treatment program.
Journal of Clinical Epidemiology.
33:645-651.
1980
|
|
| 1980
|
Application of survival analysis techniques to evaluation of factors affecting compliance in a clinical trial of hypertension control.
Contemporary Clinical Trials.
1:59-69.
1980
|
|
| 1980
|
Impact of hypertension information on high blood pressure control between 1973 and 1978.
Hypertension.
2:708-713.
1980
|
|
| 1980
|
Mortality surveillance in collaborative trials.
American Journal of Public Health.
70:394-400.
1980
|
|
| 1978
|
Separate mRNAs code for tubulin subunits..
Nature.
272:81-83.
1978
|
|
| 1976
|
SODIUM EXCRETION AND SYMPATHETIC ACTIVITY IN RELATION TO SEVERITY OF HYPERTENSIVE DISEASE
1976
|
|
| 1976
|
Some examples for teaching regression toward the mean from a sampling viewpoint.
American Statistician.
30:194-197.
1976
|
|
| 1886
|
Injustice to Dr. barnes.
Journal of the American Medical Association.
VI:498.
1886
|
|
